



Secondhand Smoke Exposure and Subclinical Cardiovascular 







A thesis submitted to Johns Hopkins University in conformity with the requirements for 









© 2015 Hoda Magid 










Few studies have evaluated the association between secondhand smoke (SHS) and 
subclinical cardiovascular disease (CVD) among ethnically diverse populations. This 
study assessed the impact of SHS on three domains of subclinical CVD (inflammation, 
atherosclerosis, and peripheral arterial disease) among 5,032 non-smoking adults 45-84 
years without prior CVD participating in the Multi-Ethnic Study of Atherosclerosis 
(MESA) from 2000 to 2002. SHS exposure was determined by self-report, and urinary 
cotinine in a subset. The multi-adjusted geometric mean ratios (95% confidence interval) 
of high sensitivity C-reactive protein comparing 407 participants with SHS ≥12 
hours/week vs 3,035 unexposed were 1.26 (1.12, 1.41) and 1.14 (1.02, 1.26) before and 
after adjustment for body mass index, respectively. The corresponding ratios for 
interleukin 6 were 1.11 (1.04, 1.18) and 1.05 (0.98, 1.11), and for internal carotid intima 
media thickness they were 1.04 (1.00, 1.09) and 1.04 (0.99, 1.08). Fibrinogen and 
coronary artery calcification were not associated with SHS. The prevalence of peripheral 
arterial disease (ABI≤0.9 or ABI≥1.4) was associated with detectable urinary cotinine 
(Odds ratio: 2.0l; 95% confidence interval: 1.13, 3.90) but not with self-reported SHS. 
Despite limited exposure assessment, this study supports the association of SHS exposure 
with hsCRP, and maybe with IL-6, internal cIMT, and peripheral arterial disease. 
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Chapter 1: Introduction 
Secondhand smoke (SHS) exposure is a global cause of morbidity and mortality.1 
A third of non-smoking adults are exposed to SHS worldwide.1 In the US, 25% of the 
population remains exposed to SHS, disproportionately affecting communities with low 
income.2 SHS is an established cardiovascular disease (CVD) risk factor.3,4 Meta-
analyses have estimated that SHS exposure is associated with a 31% increased risk of 
coronary heart disease3 and 20-30% increased risk of stroke.5-7 The enactment of indoor 
smoke-free policies have been followed by important reductions in coronary heart disease 
hospitalizations,8 providing additional evidence on the potential cardiovascular benefits 
of reducing SHS exposure in the population. The 2014 Surgeon General Report, however, 
estimated that around 33,000 non-smokers die every year from SHS-related coronary 
heart disease in the US.6 
Possible mechanisms for SHS-related cardiovascular toxicity include increased 
platelet aggregability, endothelial dysfunction, inflammation, oxidative stress, arterial 
stiffness and atherosclerosis.9-13 Relatively few studies have evaluated the association 
between SHS exposure and subclinical CVD among ethnically diverse populations at 
currently relevant levels of exposure.  Self-reported SHS exposure has been associated 
with carotid intima media thickness (cIMT) and coronary artery calcification (CAC) in 
studies from the United States14-17 and Europe,18,19 although most studies were conducted 
several decades ago. Few studies have evaluated the association between SHS and 
peripheral arterial disease, with inconsistent findings.20-22 With mostly supportive 
findings, a larger body of evidence is available for the association between SHS exposure 
and high-sensitive C-reactive protein (hsCRP), including studies among adolescents,23-26 
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pregnant women,27 and adults.28-36 Studies evaluating the association between self-
reported or biomarker-based SHS exposure and fibrinogen have generally shown 
consistent positive associations.32-35,37 For interleukin 6 (IL-6), the evidence is largely 
null, although most studies are small.28,29,32 
The Multi-Ethnic Study of Atherosclerosis (MESA) was specifically designed to 
assess subclinical cardiovascular disease and its risk factors among an ethnically diverse, 
community-based cohort from six urban communities around the United States. MESA 
provides a unique opportunity to inform our understanding of relevant mechanistic 
pathways for cardiovascular disease at modern levels of SHS exposure. In this study, our 
objective was to examine the cross-sectional association of SHS exposure with markers 
of inflammation, subclinical atherosclerosis, and peripheral arterial disease in non-
smoking MESA participants. SHS exposure was assessed by self-report in the overall 











Chapter 2: Methods 
2. 1 Study population 
MESA is a community-based prospective cohort study of 6,814 White, African-
American, Hispanic, or Chinese-American men and women ages 45 to 84 years old who 
were free of clinically apparent CVD at the baseline examination between July 2000 and 
2002. Details of the study design, recruitment, and data collection have previously been 
published.38 Participants were enrolled from Forsyth County, North Carolina; New York 
City, New York; Baltimore, Maryland; St. Paul, Minnesota; Chicago, Illinois; and Los 
Angeles, California. The race/ethnicity distribution was as follows: 39% non-Hispanic 
whites, 28% African-Americans, 22% Hispanics, and 12% Chinese-Americans.   All 
field-centers’ institutional review boards approved the study and all participants provided 
written informed consent.  
For this study, we excluded 887 participants who were current smokers based on 
self-report, 107 participants with urinary cotinine concentrations above concentrations 
≥200 ng/mL (likely current smokers),39,40 149 participants missing data on self-reported 
SHS exposure, and 639 participants missing other variables of interest, leaving 5,032 
participants for this analysis (Figure 1). Among them, 2,983 participants had urinary 
cotinine available. Urinary cotinine, a specific biomarker of recent SHS exposure,41 was 
analyzed in a random subsample of MESA participants who were enrolled into the 
MESA Lung sub-study (n=3,965).  Sociodemographic characteristics in our study 
population for analyses based on self-reported SHS exposure (n=5,032) and urinary 
cotinine (n=2,983) were similar to the overall non-current smoking MESA population 
(Supplementary Table 1). 
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Supplementary Table 1: Sociodemographic Characteristics of 5,032 Non-Smoking 
MESA Participants by Smoking Status Exposure Assessment 

























N 5,032 2,983 5,820 
Men 46.0 47.3 45.8 
Age 62.5 (10.3) 61.63 (9.96) 62.76 (10.28) 
Race/Ethnicity    
      White 39.5 35.9 39.0 
      African-American 24.1 22.5 26.2 
      Chinese-American 14.1 18.8 12.9 
      Hispanic 22.4 22.8 22.0 
Study Site     
      WFU 14.2 13.9 15.3 
      COL 16.3 18.2 16.0 
      JHU 14.6 11.7 15.9 
      UMN 15.2 13.3 15.1 
      NWU 18.4 20.0 17.6 
      UCLA 21.2 23.4 20.2 
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2.2 Data collection 
During the baseline examination, standardized questionnaires were used to obtain 
demographic information, level of education, family income, current alcohol and tobacco 
use, medical history, medication use, family history of CVD. The examination was 
conducted in the morning after 12 hours of fasting using calibrated devices. Body mass 
index (BMI) was calculated as measured weight in kilograms divided by measured height 
in meters squared. Resting heart rate was measured on all participants using a 12-lead 
electrocardiogram [(ECG), (Marquette MAC-1200; GE Healthcare, Milwaukee, WI, 
USA)] for three consecutive 10-second recordings. Systolic and diastolic resting blood 
pressures were measured in seated position using Critikon Dinamap Pro 100 (Critikon, 
Tampa, Florida). The average of the second and third of three blood pressure 
measurements taken 2 minutes apart were used in the analyses. Hypertension was defined 
as a systolic blood pressure ≥140 mmHg, a diastolic blood pressure ≥90 mmHg, or the 
use of medications for hypertension.42  
Lipids including total and HDL cholesterol, triglycerides, and glucose levels were 
measured from fasting plasma samples in a central laboratory (University of Vermont, 
Burlington, VT).43  Total cholesterol was measured from plasma using a cholesterol 
oxidase method (Roche Diagnostics, Indianapolis, IN) on a Roche COBAS FARA 
centrifugal analyzer. High-density lipoprotein cholesterol (HDL-C) was measured using 
the cholesterol oxidase method (Roche Diagnostics, Indianapolis, IN) after precipitation 
of non-HDL with magnesium/dextran.44 Triglycerides were measured using a glycerol-
blanked enzymatic method (Roche Diagnostics, Indianapolis, IN) on the Roche COBAS 
FARA centrifugal analyzer. Low-density lipoprotein cholesterol (LDL-C) was calculated 
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by the Friedewald equation among participants with a triglyceride value <400 mg/dL.45 
Diabetes was defined by the use of insulin or oral hypoglycemic medication or a fasting 
blood glucose of ≥126 mg/dL.46 Participants were considered to have impaired fasting 
glucose if they did not have diabetes according to the preceding criteria but their fasting 
blood glucose level was ≥100 to <126 mg/dL.  
Physical activity was measured by the MESA Typical Week Physical Activity Survey 
(TWPAS), adapted from the Cross-Cultural Activity Participation Study47 designed to 
identify the time spent in and frequency of various physical activities including light, 
moderate, and heavy-intensity activities. Minutes of activity were summed for each 
discrete activity type and multiplied by metabolic equivalent (MET) level. For the present 
analysis, we used a summary variable for physical activity defined as the sum of 
moderate and vigorous physical activity (MVPA) in MET-minutes/day. Minutes of 
activities per week were converted to hours for ease of presentation.  
2.3 Secondhand smoke exposure 
Information on current SHS exposure was obtained by asking non-current smoking 
participants the following question: “During the past year about how many hours per 
week were you in close contact with people when they were smoking? (e.g. in your home, 
in a car, at work or other close quarters).” Urinary cotinine (ng/mL) was measured by 
immunoassay LLD (lower detection limit)  (Immulite 2000 Nicotine Metabolite Assay; 
Diagnostic Products Corp., Los Angeles, CA) as part of MESA Lung.40 The urinary 
cotinine detection level was 10 ng/mL. In our study population, only 10% (n=299) non-
smoking participants with urinary cotinine measurements available had detectable urinary 
cotinine concentrations.   
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2.4 Inflammation 
Serum hsCRP was measured using a high-sensitivity assay (N-High-Sensitivity 
CRP; Dade Behring, Deerfield, IL). The intra-assay coefficient of variation (CV) for 
hsCRP ranged from 2.3-4.4% and the inter-assay CV ranged from 2.1-5.7%. IL-6 was 
measured by ultrasensitive enzyme-linked immunosorbent assay (Quantikine HS Human 
IL-6 Immunoassay; R&D Systems, Minneapolis, MN). The laboratory CV for this assay 
is 6.3%.48 Serum fibrinogen was measured using immunoprecipitation of fibrinogen 
antigen using the BNII nephelometer (N-Antiserum to Human Fibrinogen; Dade Behring 
Inc., Deerfield, IL) with intra- and inter-assay coefficients of variations (CV) as 2.7% and 
2.6%, respectively. We evaluated inflammation markers as continuous outcomes. For 
hsCRP, we also utilized hsCRP ≥2 mg/L based on  the Justification for the Use of Statins 
in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial 
which encouraged the use of hsCRP ≥2 mg/L as a screening tool for statin therapy.49 
2.5 Subclinical atherosclerosis 
The right and left common carotid and internal carotid arteries and the near and far 
walls were imaged during carotid ultrasonography according to a scanning protocol using 
high- resolution B-mode ultrasound with a Logiq 700 machine (General Electric Medical 
Systems, Waukesha, Wisconsin)50. Images were digitized and analyzed centrally at the 
MESA ultrasound reading center (Tufts Medical Center). We defined internal and 
common carotid artery IMT as the mean of the maximum cIMT of the near and far walls 
on the right and left sides similar to previous MESA studies.51,52  
For coronary artery calcium (CAC) measures, cardiac CT was performed using either 
a cardiac-gated electron beam CT scanner (Imatron C-150XL, GE-Imatron, San 
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Francisco, CA) or using a 4- slice multi-detector CT instrument acquiring slices for each 
cardiac cycle in a sequential or axial scan mode. Images were centrally read at the MESA 
CT reading center (Harbor–University of California, Los Angeles). The scanning 
protocol for MESA has been previously published.53 For each scan, the total phantom-
adjusted Agatston score, defined as the sum of calcium measures from the left anterior 
descending, circumflex, and left and right coronary arteries, was calculated; the mean 
score was used in these analyses. We quantified CAC as two binary measures; 1) present 
(CAC>0) versus absent; or 2) less than versus greater than the 75th percentile. 
2.6 Peripheral arterial disease 
Ankle-Brachial Index (ABI) measurements were obtained after resting in supine 
position for 5 minutes using a specific protocol to measure systolic blood pressure in each 
posterior tibial and dorsalis pedis artery in both legs and in the brachial artery in both 
arms. All blood pressure measurements were detected with a continuous-wave Doppler 
ultrasound probe. For each leg, the ABI was calculated as the higher of the posterior 
tibial or dorsalis pedis systolic pressures in each leg divided by the higher of the 2 
systolic blood pressure measurements in both arms. For this study, we quantified ABI as 
three binary measurements: 1) ABI≤0.9 (excluding participants with ABI ≥1.4), 2) 
ABI≥1.4 (excluding participants with ABI ≤0.9), and 3) ABI≤0.9 or ABI≥1.4 in 
accordance with previous MESA studies showing both low and high ABI were associated 
with CVD events.54 
2.7 Statistical analysis 
Descriptive statistics were utilized to describe sociodemographic and 
cardiovascular risk factors overall and by SHS exposure (no exposure and quartiles of 
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hours per week) at baseline. Non-normally distributed variables including hsCRP, IL-6, 
Fibrinogen, and cIMT were log-transformed (natural logarithm) to improve normality. 
Analysis of variance and Chi-squared tests were used to compare differences in means 
and proportions across categories of SHS exposure, respectively.  
Multivariable linear regression models on log-transformed CVD markers (hsCRP, 
IL-6, Fibrinogen, and cIMT) were used to estimate geometric mean ratios comparing 
continuous CVD marker levels by SHS exposure category. For dichotomous outcomes 
(hsCRP≥2, CAC>0, CAC>75th percentile, ABI≤0.9, ABI≥1.4, and ABI≤0.9 or ABI≥1.4 ), 
we calculated prevalence odds ratios by SHS exposure using multivariate logistic 
regression. Hours of SHS exposure per week were modeled as categorical with five 
categories and zero hours of self-reported SHS exposure per week as the reference 
category. Models were adjusted for covariates in a progressive manner. Model 1 adjusted 
for age, gender, race/ethnicity, study site, education (high school or less or more than 
high school), and income (<$25,000 or ≥$25,000/year). Model 2 included model 1 
variables plus hypertension (yes or no), diabetes (yes or no), LDL-C (mg/dL), treatment 
for dyslipidemia (yes or no), physical activity (MET-hrs/week), and cigarette smoking 
status (never or former). Model 3 included model 2 variables and BMI (kg/m2). For all 
analyses, P-values for trend were obtained by including a continuous variable with the 
medians corresponding to each quartile of the SHS exposure distribution in the regression 
model.55 
We evaluated effect measure modification of the fully adjusted association 
between SHS exposure and continuous subclinical CVD markers by categories of gender, 
age, race/ethnicity, study site, education, and cigarette smoking status entering the 
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product of SHS exposure (≥12 hours of per week to unexposed) by participant subgroups 
of interest. For all outcomes, estimated 2-sided P values for the interactions between SHS 
exposure and the characteristics evaluated were computed using the Wald test. We did 
not evaluate effect measure modification of dichotomous outcomes due to limited power. 
In the subsample of participants with urinary cotinine available (n=2,983), we 
evaluated the association of urinary cotinine with our three domains of cardiovascular 
disease. Urinary cotinine was modeled as a binary outcome:  detectable vs. non-
detectable urinary cotinine. Among the subset of participants with detectable urinary 
cotinine (n=299), we conducted linear regression analyses for continuous outcomes 
modeling cotinine as log-transformed. 
We also ran several sensitivity analyses. First, we repeated models 2 and 3 for 
each outcome adjusting for alcohol use (n=3,962; data not shown), family history of 
CHD (n=4,713), heart rate (n=4,999), and education levels using three categorical 
variables (high school or less, some college but no degree/technical school certificate, 
associates degree/bachelors degree/graduate degree) instead of two.  Second, we ran all 
analyses evaluating the association between SHS exposure and the 3 domains of CVD 
while defining SHS as binary (exposed or unexposed). Third, we ran all analyses 
comparing participants with ≥12 Hrs/week of SHS vs 1 Hr/week as the reference. Finally, 
all analyses were performed based on self-reported SHS exposure only, without using 
cotinine to exclude potential current smokers. For all sensitivity analyses, we observed 
similar patterns and inference to those in the main analysis (data not shown).  
Statistical analyses were performed with Stata Version 13.0 (StataCorp, College 
Station, TX, USA) and R Version 3.03 (R Foundation for Statistical Computing, www.r-
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project.org, Vienna, Austria). All statistical tests were two-sided, and P-values less than 




















Chapter 3: Results 
3.1 Participant Characteristics. The median (interquartile range) of SHS exposure was 
0 (0, 2) hours per week. 39.7% (n=1,997) of participants self-reported 1 hour or more of 
SHS exposure per week and 8.1% (n=407) reported 12 hours or more of SHS exposure 
per week. Former smokers comprised 41% of the study sample. Participants with higher 
SHS exposure were more likely to have lower income, be former smokers, have higher 
BMI, and have less education (Table 1). They also tended to have higher physical activity 
levels. Participants in the highest SHS exposure category were more likely to have 













Table 1: Characteristics of 5,032 MESA Participants by Secondhand Smoke Exposure, 2000-2002.a-c 
 
 
Overall Unexposed 1 Hr/Wk 2-3 Hrs/Wk 4-10 Hrs/Wk ≥12 Hrs/Wk P-Value 
N 5,032 3,035 682 428 480 407  
Sociodemographic Factors   
Men 46.0 44.1 50.0 47.4 53.3 43.2 <0.001 
Age 62.5 (10.3) 63.9 (10.4) 59.8 (9.8) 61.1 (10) 60.5 (9.6) 60.5 (9.3) <0.001 
Race/Ethnicity        <0.001 
      White 39.5 35.3 50.6 43.7 44.2 41.5  
      African-American 24.1 21.0 24.1 29.4 31.0 33.7  
      Chinese-American 14.1 17.9 10.0 10.1 7.3 5.2  
      Hispanic 22.4 25.9 15.4 16.8 17.5 19.7  
High school or less 35.0 38.1 22.0 30.4 33.8 40.0 <0.001 
Less than $25,000/year 31.3 36.8 18.5 22.4 26.3 27.3 <0.001 
Cardiovascular Disease Risk Factors        
Family History of CHD 41.2 39.7 43.5 44.3 44.9 42.2 0.14 
Current alcohol use† 68.4 65.1 74.0 74.7 69.0 72.5 <0.001 
Former Smokers 40.9 37.4 45.9 44.2 49.0 46.4 <0.001 
BMI, kg/m2 28.2 (5.4) 27.7 (5.4) 28.2 (5.2) 28.5 (5.3) 29.1 (5.6) 30.0 (5.7) <0.001 
Physical activity (MET-hrs/wk) 94.6 (97.9) 82.1 (80.3) 100.9 (102.8) 113.4 (131.3) 130.6 (130.6) 115.3 (104.3) <0.001 
Hypertension 44.5 45.5 39.0 43.2 43.3 48.4 0.01 
Systolic blood pressure, mmHg 126.4 (21.4) 127.1 (21.9) 123.8 (20.1) 126.1 (20.9) 124.5 (19.8) 128.0 (21.5) <0.001 
Diabetes 11.8 12.3 7.6 14.0 11.7 13.3 0.005 
Fasting glucose, mg/dL 96.7 (29.1) 97 (29.5) 93.3 (21.8) 96 (27) 98.2 (33.6) 98.9 (32) 0.01 
Lipid lowering medications 16.6 17.3 13.9 18.2 15.8 14.5 0.14 
Total cholesterol, mg/dL 194.3 (34.6) 193.6 (34.2) 196.2 (35) 193.2 (34.9) 195 (36.8) 196.2 (33.8) 0.47 
LDL-C, mg/dL 117.6 (31.3) 116.9 (30.8) 119.1 (32.1) 118 (32.2) 118.4 (32.7) 118.3 (30.7) 0.47 
Heart rate, bpm 62.9 (9.5) 63 (9.5) 61.7 (9.2) 63.1 (9.7) 63.4 (9.8) 63.7 (9.3) <0.01 
Urinary cotinine†, ng/ml 10.9 (14.6) 8.8 (9.7) 11.2 (16.5) 9.8 (7.8) 15.4 (20.8) 22.4 (27.2) <0.001 
Detectable Urinary Cotinine† 10.0 4.6 10.5 9.4 22.2 36.9 <0.001 
Inflammation Markers        
hsCRP, mg/L 1.8 (0.8, 4.0) 1.6 (0.7, 3.8) 1.8 (0.8, 3.8) 1.8 (0.8, 4.5) 1.9 (0.8, 4.2) 2.4 (1.1, 5.0) 0.04 
hsCRP≥2, mg/L 45.7 43.5 45.3 48.1 48.1 57.0 <0.001 
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Abbreviations:  ABI, ankle brachial index; BMI, body mass index; CAC, coronary artery calcification; cIMT, carotid intima-media thickness; Hrs/Wk, hours per 
week; hsCRP, high-sensitivity c-reactive protein; IL-6, Interleukin-6; LDL-C, low density lipoprotein cholesterol; MET, metabolic equivalent.  
aAll values are mean (standard deviation), proportion (%), or median (IQR) 
bP-values are differences between groups using one-way ANOVA, or Chi-square as appropriate 






IL-6, pg/ml 1.5 (1.2) 1.5 (1.2) 1.4 (1) 1.5 (1.1) 1.4 (1.1) 1.6 (1.2) 0.01 
Fibrinogen, mg/dL 343.9 (72.1) 346.5 (72.3) 339.5 (70.5) 338.2 (76.5) 335.4 (69.2) 347.9 (71) <0.001 
Subclincal Atherosclerosis Markers        
Internal cIMT, mm 1.05 (0.59) 1.05 (0.59) 1.00 (0.54) 1.05 (0.60) 1.05 (0.57) 1.10 (0.67) 0.19 
Common cIMT, mm 0.87 (0.19) 0.87 (0.20) 0.85 (0.18) 0.87 (0.19) 0.86 (0.19) 0.88 (0.18) 0.03 
CAC>0 49.2 51.6 41.9 47.9 48.3 45.7 <0.001 
CAC≥75th percentile  25.0 26.8 20.1 21.3 24.6 24.6 0.002 
Peripheral Arterial Disease Markers        
ABI≤0.9 2.9 3.1 1.9 3.5 2.1 3.4 0.31 
ABI≥1.4 0.6 0.6 0.3 0.7 1.3 1.0 0.27 
ABI≤0.9 or ABI≥1.4 3.52 3.62 2.20 4.21 3.33 4.42 0.27 
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3.2 SHS and inflammation. After adjustment for age, gender, race/ethnicity, study site, 
education, income, hypertension, diabetes, LDL-C, treatment for dyslipidemia, physical 
activity, smoking status, and BMI, participants with ≥12 hours of SHS exposure per week 
compared to unexposed showed 26% and 11% higher hsCRP and IL-6 levels respectively 
and a statistically significant trend was observed across increasing categories of SHS 
exposure for both inflammatory markers (Table 2, model 2). The associations were 
markedly attenuated for both hsCRP and IL-6 after adjustment for BMI (model 3), and 
only the association with hsCRP remained statistically significant (geometric mean ratio: 
1.14; 95% confidence interval: 1.02, 1.26). The odds ratio of hsCRP≥2 mg/L was 1.52 
(95% confidence interval: 1.21, 1.90) before adjustment for BMI and 1.33 (95% 
confidence interval: 1.05, 1.69) after adjustment for BMI. No association was found 




Table 2: Association between Secondhand Smoke Exposure and Inflammation. 
 Unexposed 1 Hr/Wk 2-3 Hrs/Wk 4-10 Hrs/Wk ≥12 Hrs/Wk P-Trend 
N 3,035 682 428 480 407  
  Value 95% CI Value 95% CI Value 95% CI Value 95% CI  
GM Ratio of hsCRP, mg/L†       
Model 1 1 (Ref) 1.08 0.98, 1.19 1.12 1.00, 1.26 1.13 1.02, 1.26 1.28 1.14, 1.43 <0.001 
Model 2 1 (Ref) 1.08 0.98, 1.18 1.13 1.01, 1.26 1.14 1.02, 1.26 1.26 1.12, 1.41 <0.001 
Model 3 1 (Ref) 1.06 0.98, 1.16 1.11 1.00, 1.23 1.08 0.98, 1.19 1.14 1.02, 1.26 0.056 
Odds Ratio of hsCRP≥2 mg/L       
Model 1 1 (Ref) 1.12 0.94, 1.34 1.20 0.97, 1.49 1.20 0.98, 1.48 1.55 1.24, 1.93 <0.001 
Model 2 1 (Ref) 1.11 0.92, 1.32 1.21 0.98, 1.51 1.22 0.99, 1.51 1.52 1.21, 1.90 <0.001  
Model 3 1 (Ref) 1.10 0.91, 1.34 1.20 0.96, 1.51 1.13 0.90, 1.40 1.33 1.05, 1.69 0.03 
GM Ratio of IL-6, pg/ml †       
Model 1 1 (Ref) 1.00 0.95, 1.06 1.03 0.96, 1.10 0.99 0.93, 1.06 1.11 1.03, 1.19 0.002 
Model 2 1 (Ref) 1.01 0.95, 1.06 1.03 0.97, 1.10 1.00 0.94. 1.06 1.11 1.04, 1.18 0.003 
Model 3 1 (Ref) 1.00 0.95, 1.05 1.02 0.96, 1.08 0.97 0.92, 1.03 1.05 0.98, 1.11 0.188 
GM Ratio of Fibrinogen, mg/dL†       
Model 1 1 (Ref) 1.00 0.99, 1.02 0.98 0.97, 1.00 0.98 0.97, 1.00 1.00 0.99, 1.03 0.407 
Model 2 1 (Ref) 1.00 0.98, 1.02 0.98 0.96, 1.00 0.99 0.97, 1.01 1.01 0.99, 1.03 0.353 
Model 3 1 (Ref) 1.00 0.98, 1.02 0.98 0.96, 1.00 0.98 0.96, 0.99 1.00 0.97, 1.02 0.764 
Abbreviations:  ABI, ankle brachial index; BMI, body mass index; CAC, coronary artery calcification; cIMT, carotid intima-media thickness; Hrs/Wk, hours per 
week; hsCRP, high-sensitivity c-reactive protein; IL-6, Interleukin-6; LDL-C, low density lipoprotein cholesterol; MET, metabolic equivalent.  
†Log-transformed 
aAll values are expressed as Odds Ratios or Geometric Mean Ratios; with 95% confidence intervals 
bSignificant values (P<0.05) are presented in bold.  
cFor all quartiles of SHS exposure, reference category is unexposed (0 hours of SHS exposure per week). 
dModel 1 is adjusted for age in years, gender (female(reference)/male), race/ethnicity (White(reference), African American, Chinese-American, Hispanic), clinic 
site(WFU(reference), COL, JHU, UMN, NWU, UCLA), education(high school or less (reference)/more than high school), and income (<$25,000/year 
(reference) / ≥$25,000/year).  
eModel 2 is adjusted for model 1 variables plus hypertension (no(reference)/yes), diabetes (normal(reference) vs untreated diabetes/treated diabetes), LDL-C 
(mg/dL), treatment for dyslipidemia (no(reference)/yes), physical activity (MET-hrs/week), and smoking status (never(reference)/former).  
fModel 3 is adjusted for model 2 variables plus BMI (kg/m2)
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3.3 SHS with subclinical atherosclerosis and peripheral arterial disease. Before 
adjustment for BMI, participants with ≥12 hours of SHS exposure per week showed 
higher internal cIMT (Geometric mean ratio: 1.04; 95% confidence interval: 1.00,1.09) 
compared to unexposed (Table 3, model 2).  The magnitude of the association remained 
similar but not significant after adjustment for BMI (model 3). Common cIMT was 
associated with SHS exposure in the model adjusted for sociodemographics but not after 
further adjustment for CVD risk factors. SHS exposure was not associated with CAC; 
neither with detectable CAC or with CAC levels higher than the 75th percentile.  SHS 
exposure was not associated with peripheral arterial disease defined as low (≤0.9), high 
(≥1.4), or both low and high ABI (≤0.9 and ≥1.4).  
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Table 3: Association of Secondhand Smoke Exposure With Subclinical Atherosclerosis and Peripheral Arterial Disease.a-f 
 Unexposed 1 Hr/Wk 2-3 Hrs/Wk 4-10 Hrs/Wk ≥12 Hrs/Wk P-Trend  
N 3,035 682 428 480 407  
  Value 95% CI Value 95% CI Value 95% CI Value 95% CI  
GM Ratio of Internal cIMT, mm†  
Model 1 1 (Ref) 1.01 0.97, 1.05 1.02 0.98, 1.07 1.02 0.98, 1.06 1.06 1.01, 1.10 0.015 
Model 2 1 (Ref) 1.00 0.97, 1.04 1.01 0.97, 1.05 1.01 0.97, 1.05 1.04 1.00, 1.09 0.051 
Model 3 1 (Ref) 1.00 0.97, 1.04 1.01 0.97, 1.05 1.01 0.97, 1.05 1.04 0.99, 1.08 0.088 
GM Ratio of Common cIMT, mm†  
Model 1 1 (Ref) 1.00 0.98, 1.02 1.01 0.99. 1.03 1.01 0.98, 1.03 1.03 1.01, 1.05 0.012 
Model 2 1 (Ref) 1.00 0.98, 1.02 1.01 0.99, 1.03 1.01 0.98, 1.02 1.02 1.00, 1.04 0.056 
Model 3 1 (Ref) 1.00 0.99, 1.02   1.00 0.99, 1.02 0.99 0.98, 1,02 1.01 0.99, 1.03 0.215 
Odds Ratio of CAC>0  
Model 1 1 (Ref) 0.81 0.67, 0.99 1.05 0.83, 1.33 1.05 0.84, 1.32 1.04 0.82, 1.33 0.53 
Model 2 1 (Ref) 0.80 0.65, 0.98 1.00 0.79, 1.27 1.00 0.79, 1.26 0.99 0.77, 1.27 0.83 
Model 3 1 (Ref) 0.80 0.65, 0.98 0.99 0.78, 1.26 0.98 0.77, 1.23 0.95 0.74, 1.21 0.88 
Odds Ratio of CAC≥75th percentile  
Model 1 1 (Ref) 0.82 0.65, 1.05 0.84 0.64, 1.12 1.06 0.82, 1.38 1.23 0.93, 1.62 0.08 
Model 2 1 (Ref) 0.81 0.64, 1.03 0.78 0.59, 1.05 1.00 0.77, 1.30 1.16 0.87, 1.54 0.17 
Model 3 1 (Ref) 0.81 0.63, 1.03 0.79 0.59, 1.05 0.98 0.75, 1.28 1.13 0.85, 1.50 0.24 
Odds Ratio of ABI≤0.9  
Model 1 1 (Ref) 0.87 0.47, 1.61 1.27 0.71, 2.27 0.76 0.38, 1.50 1.23 0.67, 2.24 0.55 
Model 2 1 (Ref) 0.91 0.49, 1.69 1.21 0.67, 2.19 0.80 0.40, 1.60 1.23 0.67, 2.26 0.53 
Model 3 1 (Ref) 0.91 0.49, 1.71 1.21 0.67, 2.18 0.82 0.41, 1.65 1.27 0.69, 2.33 0.47 
Odds Ratio of ABI≥1.4  
Model 1 1 (Ref) 0.42 0.09, 1.86 1.06 0.30, 3.69 1.90 0.72, 5.01 1.71 0.55, 5.29 0.22 
Model 2 1 (Ref) 0.44 0.10, 1.97 0.98 0.28, 3.46 1.83 0.68, 4.91 1.71 0.54, 5.35 0.23 
Model 3 1 (Ref) 0.44 0.10, 1.97 0.98 0.28, 3.47 1.76 0.65, 4.75 1.62 0.52, 5.12 0.27 
Odds Ratio of ABI≤0.9 or ABI≥1.4           
Model 1 1 (Ref) 0.74 0.42, 1.30 1.21 0.71, 2.05 0.95 0.55, 1.66 1.29 0.76, 2.19 0.309   
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Model 2 1 (Ref) 0.76 0.43, 1.34 1.12 0.66, 1.92 0.97 0.55, 1.70 1.26 0.74, 2.16 0.350 
Model 3 1 (Ref) 0.76 0.43, 1.35 1.12 0.77, 1.92 0.98 0.56, 1.72 1.28 0.75, 2.19 0.327 
Abbreviations:  ABI, ankle brachial index; BMI, body mass index; CAC, coronary artery calcification; cIMT, carotid intima-media thickness; Hrs/Wk, hours per 
week; hsCRP, high-sensitivity c-reactive protein; IL-6, Interleukin-6; LDL-C, low density lipoprotein cholesterol; MET, metabolic equivalent.  
†Log-transformed 
aAll values are expressed as Odds Ratios or Geometric Mean Ratios; with 95% confidence intervals 
bSignificant values (P<0.05) are presented in bold.  
cFor all quartiles of SHS exposure, reference category is unexposed (0 hours of SHS exposure per week). 
dModel 1 is adjusted for age in years, gender (female(reference)/male), race/ethnicity (White(reference), African American, Chinese-American, Hispanic), clinic 
site(WFU(reference), COL, JHU, UMN, NWU, UCLA), education(high school or less (reference)/more than high school), and income (<$25,000/year 
(reference) / ≥$25,000/year).  
eModel 2 is adjusted for model 1 variables plus hypertension (no(reference)/yes), diabetes (normal(reference) vs untreated diabetes/treated diabetes), LDL-C 
(mg/dL), treatment for dyslipidemia (no(reference)/yes), physical activity (MET-hrs/week), and smoking status (never(reference)/former).  












3.4 Effect measure modification. For fibrinogen, the lack of association with SHS 
exposure remained consistent across participant subgroups evaluated (data not shown). 
For hsCRP and IL-6, we found no evidence of interaction by participant characteristics, 
except for IL-6 by study site, with a markedly stronger association in Los Angeles 
compared to other sites (Geometric mean ratio: 1.40, 95% confidence interval 1.14-1.72, 
P-interaction=0.03) (Figures 2 and 3). The association between SHS exposure and carotid 
IMT (common cIMT and internal cIMT) was also consistent across most sub-groups 































Figure 2: Geometric Mean Ratios of hsCRP Comparing Quartile 4 of SHS to 





Figure 3: Geometric Mean Ratios of IL-6 Comparing Quartile 4 of SHS to 
Unexposed, Stratified by Participant Characteristics. 
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Figure 4: Geometric Mean Ratios of Common cIMT Comparing Quartile 4 of SHS 
to Unexposed, Stratified by Participant Characteristics. 
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Figure 5: Geometric Mean Ratios of Internal cIMT Comparing Quartile 4 of SHS to 
Unexposed, Stratified by Participant Characteristics. 
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3.5 Urinary cotinine. We found no fully adjusted association between detectable urinary 
cotinine with inflammatory or subclinical atherosclerosis markers (Table 4).  For 
peripheral arterial disease, the fully adjusted odds ratio for ABI ≤0.9 or ABI≥1.4 was 
2.01 (95% confidence interval: 1.13, 3.90) (Table 4, model 3). Among those with 
detectable urinary cotinine (n=299), we found no associations between log-transformed 
cotinine levels and continuous outcome measures (Table 5), although the geometric mean 
ratios were positive and consistent with our findings based on self-reported SHS exposure 
for hsCRP and IL-6.  
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Table 4: Association of Detectable Urinary Cotinine with Three Domains of Cardiovascular Disease.a-f 
 Model 1 Model 2 Model 3 
N=2,983 Value 95% CI Value 95% CI Value 95% CI 
Inflammation Markers    
GM Ratio of hsCRP, mg/L† 1.12 0.98, 1.28 1.10 0.97, 1.25 1.01    0.90, 1.14 
Odds Ratio of hsCRP≥2 mg/L† 1.11 0.86, 1.43 1.04 0.08, 1.35 0.91 0.69, 1.21 
GM Ratio of IL-6, pg/ml† 1.07 0.99, 1.15 1.06    0.98, 1.14 1.01 0.94, 1.08 
GM Ratio of Fibrinogen, mg/dL† 0.98 0.96, 1.01 0.99 0.96, 1.01 0.98 0.95, 0.99 
Subclinical Atherosclerosis Markers    
GM Ratio of Internal cIMT, mm† 1.07 1.02, 1.12 1.05 0.99, 1.10 1.04 0.99, 1.10 
GM Ratio of Common cIMT, mm† 1.02 0.99, 1.04 1.01 0.99, 1.03 1.00 0.98, 1.02 
Odds Ratio of CAC>0 1.10 0.82, 1.43 1.01 0.76, 1.34 0.99 1.74, 1.30 
Odds Ratio of CAC≥75th percentile 1.07 0.78, 1.48 0.99 0.71, 1.38 0.97 0.60, 1.34 
Peripheral Arterial Disease Markers    
Odds Ratio of ABI≤0.9 2.23 1.10, 4.49 1.96 0.96, 4.02 2.05 0.98, 4.29 
Odds Ratio of ABI≥1.4 1.89 0.60, 5.93 1.81 0.56, 5.82 1.76 0.54, 5.70 
Odds Ratio of ABI≤0.9 or ABI≥1.4 2.15 1.18, 3.91 2.01 1.09, 3.70 2.01 1.13, 3.90 
Abbreviations:  ABI, ankle brachial index; BMI, body mass index; CAC, coronary artery calcification; cIMT, carotid intima-media thickness; Hrs/Wk, hours per 
week; hsCRP, high-sensitivity c-reactive protein; IL-6, Interleukin-6; LDL-C, low density lipoprotein cholesterol; MET, metabolic equivalent.  
†Log-transformed 
aAll values are expressed as Odds Ratios or Geometric Mean Ratios; with 95% confidence intervals 
bSignificant values (P<0.05) are presented in bold.  
cFor all quartiles of SHS exposure, reference category is unexposed (0 hours of SHS exposure per week). 
dModel 1 is adjusted for age in years, gender (female(reference)/male), race/ethnicity (White(reference), African American, Chinese-American, Hispanic), clinic 
site(WFU(reference), COL, JHU, UMN, NWU, UCLA), education(high school or less (reference)/more than high school), and income (<$25,000/year 
(reference) / ≥$25,000/year).  
eModel 2 is adjusted for model 1 variables plus hypertension (no(reference)/yes), diabetes (normal(reference) vs untreated diabetes/treated diabetes), LDL-C 
(mg/dL), treatment for dyslipidemia (no(reference)/yes), physical activity (MET-hrs/week), and smoking status (never(reference)/former).  




Table 5: Association of Urinary Cotinine (Log Transformed) with Three Domains of Cardiovascular Disease.a-f 
 Model 1 Model 2 Model 3 
N=299 Value 95% CI Value 95% CI Value 95% CI 
Inflammation Markers    
GM Ratio of hsCRP, mg/L† 1.09 0.89, 1.34 1.06 0.87, 1.30 1.05 0.87, 1.27 
GM Ratio of IL-6, pg/ml† 1.09 0.97, 1.23 1.09 0.96, 1.28 1.08 0.97, 1.21 
GM Ratio of Fibrinogen, mg/dL† 0.99 0.96, 1.04 0.99 0.95, 1.03 0.99 0.95, 1.03 
Subclinical Atherosclerosis Markers    
GM Ratio of Internal cIMT, mm† 1.02 0.94, 1.11 1.01 0.93, 1.10 1.01 0.93, 1.10 
GM Ratio of Common cIMT, mm† 1.02 0.98, 1.06 1.01 0.98, 1.05 1.01 0.98, 1.05 
Abbreviations: cIMT, carotid intima-media thickness; hsCRP, high-sensitivity c-reactive protein; IL-6, Interleukin-6 
†Log-transformed 
aAll values are expressed as Geometric Mean Ratios with 95% confidence intervals 
bSignificant values (P<0.05) are presented in bold.  
cFor all quartiles of SHS exposure, reference category is unexposed (0 hours of SHS exposure per week). 
dModel 1 is adjusted for age in years, gender (female(reference)/male), race/ethnicity (White(reference), African American, Chinese-American, Hispanic), clinic 
site(WFU(reference), COL, JHU, UMN, NWU, UCLA), education(high school or less (reference)/more than high school), and income (<$25,000/year 
(reference) / ≥$25,000/year).  
eModel 2 is adjusted for model 1 variables plus hypertension (no(reference)/yes), diabetes (normal(reference) vs untreated diabetes/treated diabetes), LDL-C 
(mg/dL), treatment for dyslipidemia (no(reference)/yes), physical activity (MET-hrs/week), and smoking status (never(reference)/former).  







Chapter 4: Discussion 
 In this ethnically diverse cohort across six urban settings in the United States, self-
reported SHS exposure was positively associated with hsCRP and maybe with IL-6 and 
internal cIMT. The associations with hsCRP and IL-6 were markedly attenuated after 
adjustment for body mass index and only the association with hsCRP remained 
significant after adjustment for BMI. Internal cIMT was only marginally associated with 
SHS exposure among those in the highest category of SHS exposure in our study (12 
hours or more of SHS exposure per week) after adjustment for sociodemographic and 
CVD risk factors. SHS exposure in this study was not associated with fibrinogen, 
common cIMT, CAC, and peripheral arterial disease. In a subset of participants with 
urinary cotinine available, detectable cotinine was associated with peripheral arterial 
disease (ABI≤0.9 or ABI≥1.4) but not with the other subclinical biomarkers evaluated. 
In our study, SHS exposure was associated with hsCRP, evaluated as both a binary 
and continuous log-transformed outcome, even after adjusting for sociodemographic risk 
factors, CVD risk factors, and BMI. Several other studies assessing the relationship 
between SHS and hsCRP have been published. Among adults most studies found an 
association between SHS exposure and hsCRP levels,29,31-34,36 although a few studies 
failed to find a significant association.28,30,35 Among children and adolescents a positive 
association was found in NHANES,26 but not in other smaller studies.23-25 These results 
persisted with various classifications of secondhand smoke exposure including 




The association between SHS exposure and hsCRP was markedly attenuated in our 
study after adjustment for BMI. This attenuation may be explained by the well-
documented positive relationship between hsCRP and BMI57-61 and could be related to 
confounding. Indeed, SHS exposure and obesity disproportionately co-occur in 
population groups with lower levels of socioeconomic status.  Alternatively, the 
attenuation of the association after adjustment for BMI could be related to mediation. The 
possibility of mediation is supported by experimental and epidemiologic evidence 
showing that SHS exposure is associated with higher adiposity and obesity levels, 
although the causality of the association is still under debate. Consistent with our findings, 
the positive association between SHS exposure and hsCRP levels was completely 
attenuated after adjustment for BMI in 479 women in the Norwegian Mother and Child 
Cohort Study.27 HsCRP has long been identified as a marker of inflammation and a major 
player in the primary prevention of clinical cardiovascular disease.62 
Our findings for fibrinogen are mostly inconsistent with other studies conducted. 
Greek34, Japanese37, Scottish33, and American30,32,35 cohort studies have demonstrated 
significant positive association between SHS exposure and fibrinogen. These studies 
have measured SHS exposure by self-reported presence and duration of SHS exposure 
and objectively by cotinine levels. Nevertheless, the one study that did not find a 
signfigant association with fibrinogen, evaluated SHS exposure both by self-report and 
also by detectable serum cotinine.28  
Similarly to fibrinogen, our favorable marginal associations for IL-6 are also not 
consistent with other studies evaluating the relationship between IL-6 and SHS exposure, 
as their findings were generally null.28,29,32 The value of assessing hsCRP, IL-6, and 
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fibrinogen for CVD event prediction has been debated. While the evidence for the 
usefulness of hsCRP in the global assessment of individual cardiovascular risk seems to 
be conclusive63-66, a consensus has not been reached for the value of assessing fibrinogen 
for CVD event prediction.67 Moreover, fibrinogen has been identified as a weak marker 
of thrombosis, and the effect of fibrinogen independently predicting BMI is minimal.68  
There have been studies suggesting an association between secondhand smoke with 
subclinical atherosclerosis and peripheral arterial disease.  Few studies that have 
evaluated the association between SHS exposure and peripheral arterial disease have 
shown and they have shown generally inconsistent findings. For example, among a 
cohort of 1209 women in China, a dose response relationship between SHS exposure and 
prevalent peripheral arterial disease was found,20 while in an NHANES 1994-2004 study 
no overall association was found.21 Furthermore, in a cohort of adult non-smokers from 
the Scottish Family Study, exposure to ≥40 hours of SHS per week was found to be 
significantly associated with increased risk of prevalent peripheral arterial disease (Odds 
ratio 5.56; 95% confidence interval: 1.82–17.06, P-value = 0.003).22 
To place our findings for measures of subclinical atherosclerosis into perspective, one 
cross-sectional analysis examining exposure to SHS and CAC found that, after 
adjustment for sociodemographic and CVD risk factors, self-reported SHS exposure was 
associated with presence of CAC (Odds ratio: 1.38; 95% confidence interval: 1.03, 1.84) 
in a cohort of 1,766 never-smokers 45-75 years of age in Germany without clinically 
manifested coronary heart disease.19 While another similar study found an odds ratio of 
1.93 (95% confidence interval: 1.49, 2.51) for high SHS exposure in a cohort of 3,098 
never smokers 40-80 years of age.17 Not only has CAC been shown to be highly 
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predictive of future cardiovascular events in MESA69, but also in other studies.70,71 
Furthermore, several studies have demonstrated increased cIMT levels with increasing 
levels of SHS exposure, although none of these studies used objective measurements of 
SHS exposure and most were conducted several decades ago.14-16,18  
 In our analysis, the main question used to assess SHS exposure presents as a 
limitation of this study as this may be a relatively crude assessment of SHS exposure and 
may not distinguish between recent and life-long exposure. The difficulty of assessing 
secondhand smoke exposure and the importance of accurate measurement of SHS 
exposure to assess disease risk has been extensively reviewed,4exposure to SHS may be 
assessed through biomarkers41 or questionnaires.72 Nicotine and its metabolites are 
commonly used to assess recent SHS exposure. Urinary cotinine is commonly used to 
differentiate between active smoking and SHS exposure, but it can be limited when 
quantifying SHS exposure levels. Although serum and saliva cotinine are generally 
preferred to quantify recent SHS exposure, they can be costly for large epidemiologic 
studies. While self-reported measures of SHS can be affected by substantial measurement 
error, they provide an important tool to assess the long-term and short-term health effects 
of SHS exposure in large epidemiologic studies.72 Limitations for SHS exposure 
assessment with self-report methods include false reporting, over/or under-reporting, 
inaccurate participant recall of SHS exposure episodes, and duration of the assessment 
period, and possibilities of type errors when estimating risk.72 Nevertheless, it has also 
been suggested that objective measures of SHS, namely using urinary cotinine are not 
error-free methods.73-75    
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Other potential limitations of this study merit consideration: (1) secondhand smoke 
exposure was modeled as a fixed exposure (measured at baseline) because data on SHS 
exposure from subsequent MESA exams was limited, (2) there is a time mismatch 
between self-reported SHS exposure over the past year with cotinine measurements 
reflecting recent (past 24 hours of exposure), (3) even though we preformed cotinine 
reclassification in half the cohort exposure misclassification for smoking status may still 
be possible among study participants. Nevertheless, results of sensitivity analyses without 
cotinine reclassification were highly consistent with our main analyses (data not shown), 
(4) urinary cotinine was only available for a subset of participants, (5) although we 
assessed the association of SHS exposure with hsCRP and fibrinogen, our study lacks 
other biomarkers of thrombosis, (6) we had outcome measurements at only one time 
point (baseline), and (7) residual confounding may remain a problem.  
Strengths of this study include using urinary coting in combination with self-reported 
hours of secondhand smoke exposure to characterize SHS exposure per week, the large 
ethnically diverse modern cohort, and rigorous measurements of CVD risk factors, 
cotinine, and other sociodemographic risk factors.  
Our study has several important public health implications. Although secondhand 
smoke exposure in the United States has decreased in recent years, measureable cotinine 
levels have been found in 25 % of nonsmokers and two out of every five children ages 3 
to 11 were exposed to secondhand smoke regularly in 2011-2012.76 This still represents 
approximately 100 million American non-smokers potentially exposed to SHS; and 
therefore even a marginal cardiovascular risk with increased SHS exposure levels has 
important population level implications. Therefore, the issue of SHS exposure assessment 
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warrants additional investigation. Standard measures of long-term SHS exposure need to 
be developed; and a specific combination of self-reported and objective measurements 
(such as serum or urinary cotinine) need to be identified for epidemiologic studies. 
Reliable indicators for SHS exposure need to be additionally identified for future 
analyses. Once reliable indicators and standard measures have been identified, the effect 
of smoke-free bans and expansion of smoke-free laws needs to be explored.  
In conclusion, these results suggest that SHS exposure may increase the risk of 
CVD by influencing inflammation, atherosclerosis, and peripheral arterial disease 
pathways.  Despite limited exposure assessment, this study supports the association of 
SHS exposure with hsCRP, and maybe with IL-6, internal cIMT, and peripheral arterial 
disease.  
Studies relating SHS exposure with markers of subclinical cardiovascular disease in 
ethnically diverse modern cohorts are lacking. This study presents novel data on the 
association between SHS exposure and subclinical CVD biomarkers in a sample of U.S 
adults from six urban settings. SHS exposure assessment based on self-report and on a 
biomarker that was undetectable in most participants, was limited and may have resulted 
in substantial non-differential measurement error and regression dilution bias. Additional 
research, improving SHS exposure assessment, for instance by measuring serum cotinine, 
a more sensitive and precise biomarker of SHS exposure would be needed to further our 
understanding of the harmful effects of secondhand smoke exposure and to explain the 
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* SHS and CVD: MESA 
* JHU Masters Thesis  
* Hoda Magid 
* 




cd "/Users/hodamagid/Dropbox/JHU Thesis/HMagid Thesis Data Analysis" 
set more off 
capture log close 
clear all 
 
log using "HMagid Thesis Data Analysis.log", replace 
 
use "HMagid MESA Thesis Dataset.dta", clear 
 
******************************************************************************** 




** Covariates ** 
**************** 
* Gender 




bys shscat: summarize age1c 
anova age1c shscat  
 
* Age Category 
tab agecat1c 
tab2 shscat agecat1c, row 




tab2 shscat race1c, row chi2 
 
* Study Site  
tab site1c 




bys shscat: tab educ1 
 
* Less Highschool 
gen educ1cat=. 
replace educ1cat=0 if educ1==0 // 0 if  highschool or less 
replace educ1cat=0 if educ1==1 
replace educ1cat=0 if educ1==2  
replace educ1cat=0 if educ1==3  
replace educ1cat=1 if educ1==4 // 1 higher than highschool 
replace educ1cat=1 if educ1==5 
replace educ1cat=1 if educ1==6 
replace educ1cat=1 if educ1==7  
replace educ1cat=1 if educ1==8 
label var educ1cat "Education Category"  
label define educ1cat 0 "Highschool or Less" 1 "Higher than Highschool" 
label values educ1cat educ1cat 
tab2 shscat educ1cat, row 
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anova educ1cat shscat  
 
* Education based on more categories  
gen educ1cat2=. 
replace educ1cat2=0 if educ1==0 // 0 if  highschool or less 
replace educ1cat2=0 if educ1==1 
replace educ1cat2=0 if educ1==2  
replace educ1cat2=0 if educ1==3  
replace educ1cat2=1 if educ1==4 // 1 if Some College (but no degree) & technical school 
certificate 
replace educ1cat2=1 if educ1==5 
replace educ1cat2=2 if educ1==6 // 2 if AA, BA, or grad school 
replace educ1cat2=2 if educ1==7  
replace educ1cat2=2 if educ1==8 
label var educ1cat "Education Category"  
label define educ1cat2 0 "Highschool or Less" 1 "Some College/Technical School 
Certificate" 2 "AA, BA, or Grad School" 
label values educ1cat2 educ1cat2 
tab2 shscat educ1cat2, row 
anova educ1cat2 shscat  
 
* Less than $25,000 per year 
gen income1cat=.  
replace income1cat=0 if income1==1 // 0 if less than $25K/year 
replace income1cat=0 if income1==2 
replace income1cat=0 if income1==3 
replace income1cat=0 if income1==4 
replace income1cat=0 if income1==5 
replace income1cat=0 if income1==6 
replace income1cat=1 if income1==7 // 1 $25K/year or higher 
replace income1cat=1 if income1==8 
replace income1cat=1 if income1==9 
replace income1cat=1 if income1==10 
replace income1cat=1 if income1==11 
replace income1cat=1 if income1==12 
replace income1cat=1 if income1==13 
label var income1cat "Income Category"  
label define income1cat 0 "Less than $25K/year " 1 "$25K/year or higher" 
label values income1cat income1cat 
tab2 shscat income1cat, row  
kwallis shscat, by(income1cat) 
 
* Current Alcohol Use 
tab2 shscat curalc1, row chi2 
 
* Former smoking status  




bys shscat: summarize bmi1c 
anova bmi1c shscat  
 
* Moderate and Vigorous Physical Activity Total (MET-min/wk M-Su) 
summarize pamvcm1c 
 
* Moderate and Vigorous Physical Activity Total (MET-hours/wk M-Su) 
gen pamvcm1chr = pamvcm1c / 60 
summarize pamvcm1chr 
bys shscat: summarize pamvcm1chr 
anova pamvcm1chr shscat  
 
* HTN 
tab2 shscat htn1c, row chi2 
 
* Family History of MI (Parent or Sibling) 
tab2 shscat fhha1c, row chi2 
 
* SBP  
bys shscat: summarize sbp1c  




* HTN Medication 





replace dm031ccat=0 if dm031c==0 // 0 if Normal  
replace dm031ccat=0 if dm031c==1 // 1 if ifg, untreated diabetes, treated diabetes 
replace dm031ccat=1 if dm031c==2 
replace dm031ccat=1 if dm031c==3 
label var dm031ccat "Diabetes Category"  
label define dm031ccat 0 "No Diabetes or IFG " 1 "Untreated, Treated Diabetes" 
label values dm031ccat dm031ccat 
tab2 shscat dm031ccat, row chi2 
 
* Fasting Glucose 
summarize glucos1c  
bys shscat: summarize glucos1c 
anova glucos1c shscat  
 
* Any Lipid Lowering Medication 
tab2 shscat lipid1c, row chi2 
 
* Total Cholestrol 
summarize chol1 
bys shscat: summarize chol1 




bys shscat: summarize ldl1 




*bys shscat: summarize hdl1 




*bys shscat: summarize trig1 
*anova trig1 shscat 
 
* Heart rate 
summarize hrtrate1 
bys shscat: summarize hrtrate1 
anova hrtrate1 shscat 
 
* Calculated urinary mean cotinine concentration (ng/ml)  
summarize CotcncAC 
bys shscat: summarize CotcncAC 
anova CotcncAC shscat  
 
* Creating 2 categories of Urinary Cotinine among never and former  
// Calculated mean cotinine concentration (ng/ml)  
codebook CotcncAC // 90th percentile overall is 16.3 
summ CotcncAC, detail 
bys shscat: summ CotcncAC, detail 
gen cot1=0 if CotcncAC<16.3 
replace cot1=1 if CotcncAC>=16.3 & CotcncAC!=. 
label var cot1 "Cotinine Category (Overall)"  
label define cot1 0 "Cot<90th" 1 "Cot>=90th" 
label values cot1 cot1 
tab2 shscat cot1, row chi2  
 
* Log Transform CotcncAC for those with detectable cotinine 
gen logcot=. 
replace logcot=ln(CotcncAC) if cot1==1 
 




*bys shscat: summarize pkyrs1c 
*anova pkyrs1c shscat 
 
* Live with a smoker as a child  
tab2 shscat qsmkada4, row chi2 
 
* Number of smokers in home as a child 
* bys shscat: summarize qsmkcna4 
* anova shscat qsmkcna4 
 
* Live with a smoker as an adult 
tab2 shscat qsmkada4, row chi2 
 
* Years Living with adult smoker 
* bys shscat: summarize qsmkana4 
* anova shscat qsmkana4 
 
* Work with smokers 
* tab2 shscat qsmkwa4, row chi2 
 
* Years working with smokers 
* bys shscat: summarize qsmkwya4 
* anova shscat qsmkwya4 
 
******************** 
** Crude Outcomes ** 
******************** 
*hsCRP // Continous 
summarize crp1, detail 
* detection level for CRP is 0.18 mg/L 
gen crpdetect=.  
replace crpdetect=0 if crp1>0.18 
replace crpdetect=1 if crp1<0.18 
tab crpdetect 
 
bys shscat: summarize crp1, detail 
anova crp1 shscat 
* Generating log CRP 
gen logcrp=ln(crp1) 
label var logcrp "Log(hs-CRP)"  
 
*hsCRP>=2 // Binary 
gen crp1cat=.  
replace crp1cat=0 if crp1<2 
replace crp1cat=1 if crp1>=2 & crp1!=. 
label var crp1cat "hsCRP>=2 Category"  
label define crp1cat 0 "hsCRP<2" 1 "hsCRP>=2" 
label values crp1cat crp1cat 
tab2 shscat crp1cat, row chi2 
 
*IL-6 // Continous 
summarize il61, 
bys shscat: summarize il61 
anova il61 shscat 
* Generating Log IL6 
gen logil61=ln(il61) 
label var logil61 "Log(IL-6)"  
 
* detection level for IL-6 is 0.18 mg/L 
gen crpdetect=.  
replace crpdetect=0 if crp1>0.18 
replace crpdetect=1 if crp1<0.18 
tab crpdetect 
 
*Fibrinogen // Continous 
summarize fib1 
bys shscat: summarize fib1 
anova fib1 shscat 




label var logfib1 "Log(Fibrinogen)"  
* detection level for Fibrinogen is 0.18 mg/L 
gen crpdetect=.  
replace crpdetect=0 if crp1>0.18 
replace crpdetect=1 if crp1<0.18 
tab crpdetect 
 
* need to check if log transforming improves normality // yes it does 
hist fib1  
hist logfib1 
 
*Internal cIMT // Continous 
summarize maxint1c 
bys shscat: summarize maxint1c 
anova maxint1c shscat 
* Generating Log Internal cIMT 
gen logint1=ln(maxint1c) 
label var logint1 "Log(Internal cIMT)"  




*Common cIMT // Continous 
summarize maxcom1c 
bys shscat: summarize maxcom1c 
anova maxcom1c shscat 
* Generating Log Internal cIMT 
gen logcom1=ln(maxcom1c) 
label var logcom1 "Log(Common cIMT)"  
 




* Low (<1) ABI // Binary 
gen abi1low=.  
replace abi1low=0 if abi1c>1 & abi1c!=. 
replace abi1low=1 if abi1c<=1 & abi1c!=. 
label var abi1low "ABI Category (<=1)"  
label define abi1low 0 "ABI>1" 1 "ABI<=1" 
label value abi1low abi1low 
tab2 shscat abi1low, row chi2 
 
* Low2 (<0.9) ABI // Binary 
gen abi1low2=.  
replace abi1low2=0 if abi1c>0.9 & abi1c!=. 
replace abi1low2=1 if abi1c<=0.9 & abi1c!=. 
label var abi1low2 "ABI Category (<=0.9)"  
label define abi1low2 0 "ABI>0.9" 1 "ABI<=0.9" 
label value abi1low2 abi1low2 
tab2 shscat abi1low2, row chi2 
 
*High(≥1.40) ABI // Binary 
gen abi1high=.  
replace abi1high=0 if abi1c<1.40 & abi1c!=. // 0 if they don't have the outcome (they are 
<1.40) 
replace abi1high=1 if abi1c>=1.40 & abi1c!=. // 1 if they do have the outcome (they are 
>=1.40) 
label var abi1high "ABI Category (>=1.40)"  
label define abi1high 0 "ABI<1.40" 1 "ABI>=1.40" 
label value abi1high abi1high 
tab2 shscat abi1high, row chi2 
 
* Combine ABI<0.9 and ABI>1.4 as one outcome variable 
gen abi1combined=.  
replace abi1combined=0 if abi1c>0.9  
replace abi1combined=0 if abi1c<1.40 
replace abi1combined=1 if abi1c<=0.9 
replace abi1combined=1 if abi1c>=1.40  
label var abi1combined "ABI Combined Category"  
label define abi1combined 0 "ABI>0.9 or ABI<1.40" 1 "ABI<=0.9 or ABI>=1.40" 
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label value abi1combined abi1combined 
tab2 shscat abi1combined, row chi2 
 
* CAC>75th // Binary // Using the AGE, GENDER, RACE-AD*JUSTED Quantiles of CAC Score 
*summ cacq1c, detail // 2474 obs 
*gen cac75adj=. 
*replace cac75adj=0 if cacq1c<0.8712991 
*replace cac75adj=1 if cacq1c>=0.8712991 & cacq1c!=. 
*label var cac75adj "CAC Category (>75th Percentile) Age,Gender,Race-Adjusted)"  
*label define cac75adj 0 "CAC<75th" 1 "CAC>=75th" 
*label value cac75adj cac75adj 
*tab cac75adj 
*tab2 shscat cac75adj, row chi2 
 
* CAC>75th // Binary // Using the mean: agatston calcium score, phantom-adjusted 
summ agatpm1c, detail 
gen cac75phadj=. 
replace cac75phadj=0 if agatpm1c<80.9625 
replace cac75phadj=1 if agatpm1c>=80.9625 & agatpm1c!=. 
label var cac75phadj "CAC Category (>75th Percentile) Phantom Adjusted)"  
label define cac75phadj 0 "CAC<75th" 1 "CAC>=75th" 
label value cac75phadj cac75phadj 
tab cac75phadj 
tab2 shscat cac75phadj, row chi2 
 
* CAC>0 // Binary 
tab cal  
gen caczero=0 if cal==0 
replace caczero=1 if cal==1|cal==2|cal==3 
label var caczero "CAC Category (>0)"  
label define caczero 0 "CAC=0" 1 "CAC>0" 
label value caczero caczero 
tab2 shscat caczero, row chi2 
 
* CAC>100 // Binary // took this out of analysis / table 1 because no differences across 
groups of SHS cat 
gen cac100=0 if cal<2 
replace cac100=1 if cal==2|cal==3 
label var cac100 "CAC Category (>100)"  
label define cac100 0 "CAC<100" 1 "CAC>100" 
label value cac100 cac100 
tab2 shscat cac100, row chi2 
 
* Generating Log CAC+1 
gen logcac1=ln(agatpm1c+1) 
 
* Generating the variable for the p-value of trend  
gen shscat_median=. 
replace shscat_median=0 if shscat==0 
replace shscat_median=1 if shscat==1 
replace shscat_median=2 if shscat==2 
replace shscat_median=6 if shscat==3 
replace shscat_median=30 if shscat==4 
 
*Generate SHS unexposed vs quartile 4 (for interaction analysis)  
gen shscat2=. 
replace shscat2=0 if shscat==0 
*replace shscat2=1 if shscat==1 
*replace shscat2=1 if shscat==2 
*replace shscat2=1 if shscat==3 
replace shscat2=1 if shscat==4 
tab shscat2 
 
*Generate SHS exposed vs unexposed (for sensitivity analysis)  
gen shscat3=. 
replace shscat3=0 if shscat==0 
replace shscat3=1 if shscat==1 
replace shscat3=1 if shscat==2 
replace shscat3=1 if shscat==3 





*Generate SHS quartile 4 vs quartile 1 (for sensitivity analysis)  
gen shscat4=. 
replace shscat4=0 if shscat==1 





save "HMagid MESA Thesis Dataset_Final.dta", replace  
******************************************************************************** 
** Aim 1 
** To assess the association (before and after adjustment for sociodemographic,  
** behavioral, and CVD risk factors ) between SHS exposure with inflammation and 
** subclinical atherosclerosis 
** Hypothesis: Secondhand smoke exposure is positively associated with  
** inflammation and subclinical atherosclerosis.  
******************************************************************************** 
* logistic command produces results in terms of odds ratios while  
* logit produces results in terms of coefficients scales in log odds  
* use nolog or at the end and its the same 
 
******************************************************************************** 
*********************** Aim 1: Inflamation *************************************  
******************************************************************************** 
 
use "HMagid MESA Thesis Dataset_Final.dta", clear 
  
*************** 
*** hsCRP ***** 
***************  
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
* For P-for trend 
xi:reg logcrp shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logcrp shscat_median gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c 
xi:reg logcrp shscat_median gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
*************** 
*** hsCRP>=2 ** 
*************** 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
* For P-for trend 
xi:logit crp1cat shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog 
or 
xi:logit crp1cat shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit crp1cat shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************** 
**** IL-6 ***** 
*************** 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
xi:reg logil61 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
 
 46 
xi:reg logil61 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logil61 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
**************** 
** Fibrinogen ** 
**************** 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
xi:reg logfib1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logfib1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logfib1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
******************************************************************************** 




*** Internal cIMT ** 
******************** 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
xi:reg logint1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logint1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logint1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
******************** 
*** Common cIMT ** 
******************** 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
xi:reg logcom1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logcom1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logcom1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
******************** 
*** CAC>75th ******* 
******************** 
* CAC>75th // Binary //  Using the mean: agatston calcium score, phantom-adjusted 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog 
or 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
xi:logit cac75phadj shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, 
nolog or 
xi:logit cac75phadj shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit cac75phadj shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 





*** CAC>0 ********** 
******************** 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
xi:logit caczero shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog 
or 
xi:logit caczero shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit caczero shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI Low (<=1) ********* 
*************************** 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
xi:logit abi1low shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog 
or 
xi:logit abi1low shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1low shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI Low (<=0.9) ******* 
*************************** 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
xi:logit abi1low2 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, 
nolog or 
xi:logit abi1low2 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1low2 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI High(≥1.40 ******** 
*************************** 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
xi:logit abi1high shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, 
nolog or 
xi:logit abi1high shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1high shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI Combined ******** 
*************************** 




xi:logit abi1combined i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1combined i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
xi:logit abi1combined shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, 
nolog or 
xi:logit abi1combined shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1combined shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
******************************************************************************** 
**** Urinary Cottinine Regression Table ***** 
******************************************************************************** 
*************** 
*** hsCRP ***** 
***************  
xi:reg logcrp cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logcrp cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c 
xi:reg logcrp cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
*************** 
*** hsCRP>=2 ** 
*************** 
xi:logit crp1cat cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit crp1cat cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit crp1cat cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************** 
**** IL-6 ***** 
*************** 
xi:reg logil61 cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logil61 cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c 
xi:reg logil61 cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
**************** 
** Fibrinogen ** 
**************** 
xi:reg logfib1 cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logfib1 cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c 
xi:reg logfib1 cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
******************** 
*** Internal cIMT ** 
******************** 
xi:reg logint1 cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logint1 cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c 
xi:reg logint1 cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
******************** 
*** Common cIMT ** 
******************** 
xi:reg logcom1 cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logcom1 cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c 
xi:reg logcom1 cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
******************** 




* CAC>75th // Binary //  Using the mean: agatston calcium score, phantom-adjusted 
xi:logit cac75phadj cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit cac75phadj cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit cac75phadj cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
******************** 
*** CAC>0 ********** 
******************** 
xi:logit caczero cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit caczero cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit caczero cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI Low (<=1) ********* 
*************************** 
xi:logit abi1low cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit abi1low cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1low cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI Low (<=0.9) ******* 
*************************** 
xi:logit abi1low2 cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit abi1low2 cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1low2 cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI High(≥1.40 ******** 
*************************** 
xi:logit abi1high cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit abi1high cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1high cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI Combined ******** 
*************************** 
xi:logit abi1combined cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit abi1combined cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1combined cot1 age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
******************************************************************************** 
**** Urinary Cottinine Regression Table ***** 
** Make the table again: Restrict the analysis to people who had cotinine  
** And then use cotinine as log transformed  
******************************************************************************** 
* Scatter plots of continous outcomes by log transformed cotinine, among those with 
detectable cotinine  
set scheme s1mono 
graph twoway (lfitci logcrp logcot) (scatter logcrp logcot) 
graph twoway (lfitci logil61 logcot) (scatter logil61 logcot) 
graph twoway (lfitci logfib1 logcot) (scatter logfib1 logcot) 
graph twoway (lfitci logint1 logcot) (scatter logint1 logcot) 
graph twoway (lfitci logcom1 logcot) (scatter logcom1 logcot) 
graph twoway (lfitci abi1c logcot) (scatter abi1c logcot) 
 
*************** 




xi:reg logcrp logcot age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logcrp logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c 
xi:reg logcrp logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
*************** 
*** hsCRP>=2 ** 
*************** 
xi:logit crp1cat logcot age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit crp1cat logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit crp1cat logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************** 
**** IL-6 ***** 
*************** 
xi:reg logil61 logcot age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logil61 logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c 
xi:reg logil61 logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
**************** 
** Fibrinogen ** 
**************** 
xi:reg logfib1 logcot age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logfib1 logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c 
xi:reg logfib1 logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
******************** 
*** Internal cIMT ** 
******************** 
xi:reg logint1 logcot age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logint1 logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c 
xi:reg logint1 logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
******************** 
*** Common cIMT ** 
******************** 
xi:reg logcom1 logcot age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logcom1 logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c 
xi:reg logcom1 logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
******************** 
*** CAC>75th ******* 
******************** 
* CAC>75th // Binary //  Using the mean: agatston calcium score, phantom-adjusted 
xi:logit cac75phadj logcot age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit cac75phadj logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit cac75phadj logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
******************** 
*** CAC>0 ********** 
******************** 
xi:logit caczero logcot age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit caczero logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit caczero logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 





*** ABI Low (<=1) ********* 
*************************** 
xi:logit abi1low logcot age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit abi1low logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1low logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI Low (<=0.9) ******* 
*************************** 
xi:logit abi1low2 logcot age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit abi1low2 logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1low2 logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI High(≥1.40 ******** 
*************************** 
xi:logit abi1high logcot age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit abi1high logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1high logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI Combined ******** 
*************************** 
xi:logit abi1combined logcot age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog 
or 
xi:logit abi1combined logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1combined logcot age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
******************************************************************************** 
** EMM // Interaction 
** Aim 2: To assess whether the association between secondhand smoke exposure // 
** and cardiovascular disease endpoints in aim 1 is modified by study site and  
** race/ethnicity, and smoking status. 
******************************************************************************** 
 
*To double check the sample sizes for the interaction analysis   
tab2 shscat2 gender 
tab2 shscat2 agecat1 
tab2 shscat2 race1c  
tab2 shscat2 site1c 
tab2 shscat2 educ1cat 
tab2 shscat2 cig1c 
 
*************** 
*** hsCRP ***** 
***************  
* Overall 
xi:reg logcrp shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
* Females  
xi:reg logcrp shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==0 
* Males 
xi:reg logcrp shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==1 
* Sex P-Value 
xi:reg logcrp shscat2 i.shscat2*gender1 gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
test _IshsXgende_1 
 
* Age  
xi:reg logcrp shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==1 
 
 52 
xi:reg logcrp shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==2 
xi:reg logcrp shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==3 
xi:reg logcrp shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==4 
* Age P-Value 
xi:reg logcrp shscat2 i.shscat2*i.agecat1c i.agecat1c gender1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c  
test _IshsXage_1_2 _IshsXage_1_3 _IshsXage_1_4 
 
* Race/Ethnicity  
* White 
xi:reg logcrp shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if race1c==1 
* Chinnese 
xi:reg logcrp shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if race1c==2 
* Black 
xi:reg logcrp shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if race1c==3 
* Hispanic 
xi:reg logcrp shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if race1c==4 
* Race P-Value 
xi:reg logcrp shscat2 i.shscat2*i.race1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 




xi:reg logcrp shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if site1c==3 
* Col 
xi:reg logcrp shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if site1c==4 
* JHU 
xi:reg logcrp shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if site1c==5 
* UMN 
xi:reg logcrp shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if site1c==6 
* NWU 
xi:reg logcrp shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if site1c==7 
* UCLA 
xi:reg logcrp shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if site1c==8 
* Site P-Value 
xi:reg logcrp shscat2 i.shscat2*i.site1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
test _IshsXsit_1_4 _IshsXsit_1_5 _IshsXsit_1_6 _IshsXsit_1_7 _IshsXsit_1_8 
 
* Education, 2 categories 
* High school or less 
xi:reg logcrp shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if educ1cat==0 
* More than high school 
xi:reg logcrp shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if educ1cat==1 
* Education P-Value 
xi:reg logcrp shscat2 i.shscat2*educ1cat gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
test _IshsXeduc1_1 
 
* Smoking Status  
* Never 
xi:reg logcrp shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 




xi:reg logcrp shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==1 
* Smoking Status P-Value 
xi:reg logcrp shscat2 i.shscat2*cig1c gender1 i.agecat1 i.race1c i.site1c educ1cat 




*** hsCRP>=2 ** 
*************** 
* Overall 
xi:logit crp1cat shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
* Females  
xi:logit crp1cat shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==0, nolog or 
* Males 
xi:logit crp1cat shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==1, nolog or 
* Sex P-Value 
xi:logit crp1cat shscat2 i.shscat2*gender1 gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXgende_1 
 
* Age  
xi:logit crp1cat shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==1, nolog or 
xi:logit crp1cat shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==2, nolog or 
xi:logit crp1cat shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==3, nolog or 
xi:logit crp1cat shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==4, nolog or 
* Age P-Value 
xi:logit crp1cat shscat2 i.shscat2*i.agecat1c i.agecat1c gender1 i.race1c i.site1c 
educ1cat income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXage_1_2 _IshsXage_1_3 _IshsXage_1_4 
 
* Race/Ethnicity  
* White 
xi:logit crp1cat shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==1, nolog or 
* Chinnese 
xi:logit crp1cat shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==2, nolog or 
* Black 
xi:logit crp1cat shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==3, nolog or 
* Hispanic 
xi:logit crp1cat shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==4, nolog or 
* Race P-Value 
xi:logit crp1cat shscat2 i.shscat2*i.race1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 




xi:logit crp1cat shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==3, nolog or 
* Col 
xi:logit crp1cat shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==4, nolog or 
* JHU 
xi:logit crp1cat shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==5, nolog or 
* UMN 
xi:logit crp1cat shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 




xi:logit crp1cat shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==7, nolog or 
* UCLA 
xi:logit crp1cat shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==8, nolog or 
* Site P-Value 
xi:logit crp1cat shscat2 i.shscat2*i.site1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXsit_1_4 _IshsXsit_1_5 _IshsXsit_1_6 _IshsXsit_1_7 _IshsXsit_1_8 
 
* Education, 2 categories 
* High school or less 
xi:logit crp1cat shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==0, nolog or 
* More than high school 
xi:logit crp1cat shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==1, nolog or 
* Education P-Value 
xi:logit crp1cat shscat2 i.shscat2*educ1cat gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXeduc1_1 
 
* Smoking Status  
* Never 
xi:logit crp1cat shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==0, nolog or 
* Former 
xi:logit crp1cat shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==1, nolog or 
* Smoking Status P-Value 
xi:logit crp1cat shscat2 i.shscat2*cig1c gender1 i.agecat1 i.race1c i.site1c educ1cat 




**** IL-6 ***** 
*************** 
* Overall 
xi:reg logil61 shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c  
* Females  
xi:reg logil61 shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==0  
* Males 
xi:reg logil61 shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==1  
* Sex P-Value 
xi:reg logil61 shscat2 i.shscat2*gender1 gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c  
test _IshsXgende_1 
 
* Age  
xi:reg logil61 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==1  
xi:reg logil61 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==2  
xi:reg logil61 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==3  
xi:reg logil61 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==4  
* Age P-Value 
xi:reg logil61 shscat2 i.shscat2*i.agecat1c i.agecat1c gender1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c  
test _IshsXage_1_2 _IshsXage_1_3 _IshsXage_1_4 
 
* Race/Ethnicity  
* White 
xi:reg logil61 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 




xi:reg logil61 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==2  
* Black 
xi:reg logil61 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==3  
* Hispanic 
xi:reg logil61 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==4  
* Race P-Value 
xi:reg logil61 shscat2 i.shscat2*i.race1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c  




xi:reg logil61 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==3  
* Col 
xi:reg logil61 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==4  
* JHU 
xi:reg logil61 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==5  
* UMN 
xi:reg logil61 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==6  
* NWU 
xi:reg logil61 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==7  
* UCLA 
xi:reg logil61 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==8  
* Site P-Value 
xi:reg logil61 shscat2 i.shscat2*i.site1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c  
test _IshsXsit_1_4 _IshsXsit_1_5 _IshsXsit_1_6 _IshsXsit_1_7 _IshsXsit_1_8 
 
* Education, 2 categories 
* High school or less 
xi:reg logil61 shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==0  
* More than high school 
xi:reg logil61 shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==1  
* Education P-Value 
xi:reg logil61 shscat2 i.shscat2*educ1cat gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c  
test _IshsXeduc1_1 
 
* Smoking Status  
* Never 
xi:reg logil61 shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==0  
* Former 
xi:reg logil61 shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==1  
* Smoking Status P-Value 
xi:reg logil61 shscat2 i.shscat2*cig1c gender1 i.agecat1 i.race1c i.site1c educ1cat 




** Fibrinogen ** 
**************** 
* Overall 
xi:reg logfib1 shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
* Females  
xi:reg logfib1 shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 




xi:reg logfib1 shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==1 
* Sex P-Value 
xi:reg logfib1 shscat2 i.shscat2*gender1 gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
test _IshsXgende_1 
 
* Age  
xi:reg logfib1 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==1 
xi:reg logfib1 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==2 
xi:reg logfib1 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==3 
xi:reg logfib1 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==4 
* Age P-Value 
xi:reg logfib1 shscat2 i.shscat2*i.agecat1c i.agecat1c gender1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c  
test _IshsXage_1_2 _IshsXage_1_3 _IshsXage_1_4 
 
* Race/Ethnicity  
* White 
xi:reg logfib1 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==1 
* Chinnese 
xi:reg logfib1 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==2 
* Black 
xi:reg logfib1 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==3 
* Hispanic 
xi:reg logfib1 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==4 
* Race P-Value 
xi:reg logfib1 shscat2 i.shscat2*i.race1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 




xi:reg logfib1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==3 
* Col 
xi:reg logfib1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==4 
* JHU 
xi:reg logfib1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==5 
* UMN 
xi:reg logfib1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==6 
* NWU 
xi:reg logfib1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==7 
* UCLA 
xi:reg logfib1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==8 
* Site P-Value 
xi:reg logfib1 shscat2 i.shscat2*i.site1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
test _IshsXsit_1_4 _IshsXsit_1_5 _IshsXsit_1_6 _IshsXsit_1_7 _IshsXsit_1_8 
 
* Education, 2 categories 
* High school or less 
xi:reg logfib1 shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==0 
* More than high school 
xi:reg logfib1 shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==1 
* Education P-Value 
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xi:reg logfib1 shscat2 i.shscat2*educ1cat gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
test _IshsXeduc1_1 
 
* Smoking Status  
* Never 
xi:reg logfib1 shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==0 
* Former 
xi:reg logfib1 shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==1 
* Smoking Status P-Value 
xi:reg logfib1 shscat2 i.shscat2*cig1c gender1 i.agecat1 i.race1c i.site1c educ1cat 




*** Internal cIMT ** 
******************** 
* Overall 
xi:reg logint1 shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
* Females  
xi:reg logint1 shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==0 
* Males 
xi:reg logint1 shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==1 
* Sex P-Value 
xi:reg logint1 shscat2 i.shscat2*gender1 gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
test _IshsXgende_1 
 
* Age  
xi:reg logint1 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==1 
xi:reg logint1 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==2 
xi:reg logint1 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==3 
xi:reg logint1 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==4 
* Age P-Value 
xi:reg logint1 shscat2 i.shscat2*i.agecat1c i.agecat1c gender1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c  
test _IshsXage_1_2 _IshsXage_1_3 _IshsXage_1_4 
 
* Race/Ethnicity  
* White 
xi:reg logint1 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==1 
* Chinnese 
xi:reg logint1 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==2 
* Black 
xi:reg logint1 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==3 
* Hispanic 
xi:reg logint1 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==4 
* Race P-Value 
xi:reg logint1 shscat2 i.shscat2*i.race1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 




xi:reg logint1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 




xi:reg logint1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==4 
* JHU 
xi:reg logint1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==5 
* UMN 
xi:reg logint1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==6 
* NWU 
xi:reg logint1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==7 
* UCLA 
xi:reg logint1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==8 
* Site P-Value 
xi:reg logint1 shscat2 i.shscat2*i.site1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
test _IshsXsit_1_4 _IshsXsit_1_5 _IshsXsit_1_6 _IshsXsit_1_7 _IshsXsit_1_8 
 
* Education, 2 categories 
* High school or less 
xi:reg logint1 shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==0 
* More than high school 
xi:reg logint1 shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==1 
* Education P-Value 
xi:reg logint1 shscat2 i.shscat2*educ1cat gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
test _IshsXeduc1_1 
 
* Smoking Status  
* Never 
xi:reg logint1 shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==0 
* Former 
xi:reg logint1 shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==1 
* Smoking Status P-Value 
xi:reg logint1 shscat2 i.shscat2*cig1c gender1 i.agecat1 i.race1c i.site1c educ1cat 




*** Common cIMT ** 
******************** 
* Overall 
xi:reg logcom1 shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
* Females  
xi:reg logcom1 shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==0 
* Males 
xi:reg logcom1 shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==1 
* Sex P-Value 
xi:reg logcom1 shscat2 i.shscat2*gender1 gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
test _IshsXgende_1 
 
* Age  
xi:reg logcom1 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==1 
xi:reg logcom1 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==2 
xi:reg logcom1 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==3 
xi:reg logcom1 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat ldl1 
lipid1c pamvcm1c cig1c bmi1c if agecat1c==4 
* Age P-Value 
 
 59 
xi:reg logcom1 shscat2 i.shscat2*i.agecat1c i.agecat1c gender1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c  
test _IshsXage_1_2 _IshsXage_1_3 _IshsXage_1_4 
 
* Race/Ethnicity  
* White 
xi:reg logcom1 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==1 
* Chinnese 
xi:reg logcom1 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==2 
* Black 
xi:reg logcom1 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==3 
* Hispanic 
xi:reg logcom1 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==4 
* Race P-Value 
xi:reg logcom1 shscat2 i.shscat2*i.race1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 




xi:reg logcom1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==3 
* Col 
xi:reg logcom1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==4 
* JHU 
xi:reg logcom1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==5 
* UMN 
xi:reg logcom1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==6 
* NWU 
xi:reg logcom1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==7 
* UCLA 
xi:reg logcom1 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==8 
* Site P-Value 
xi:reg logcom1 shscat2 i.shscat2*i.site1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
test _IshsXsit_1_4 _IshsXsit_1_5 _IshsXsit_1_6 _IshsXsit_1_7 _IshsXsit_1_8 
 
* Education, 2 categories 
* High school or less 
xi:reg logcom1 shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==0 
* More than high school 
xi:reg logcom1 shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==1 
* Education P-Value 
xi:reg logcom1 shscat2 i.shscat2*educ1cat gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
test _IshsXeduc1_1 
 
* Smoking Status  
* Never 
xi:reg logcom1 shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==0 
* Former 
xi:reg logcom1 shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==1 
* Smoking Status P-Value 
xi:reg logcom1 shscat2 i.shscat2*cig1c gender1 i.agecat1 i.race1c i.site1c educ1cat 







*** CAC>75th ******* 
******************** 
* Overall 
xi:logit cac75phadj shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
* Females  
xi:logit cac75phadj shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==0, nolog or 
* Males 
xi:logit cac75phadj shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==1, nolog or 
* Sex P-Value 
xi:logit cac75phadj shscat2 i.shscat2*gender1 gender1 i.agecat1 i.race1c i.site1c 
educ1cat income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXgende_1 
 
* Age  
xi:logit cac75phadj shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==1, nolog or 
xi:logit cac75phadj shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==2, nolog or 
xi:logit cac75phadj shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==3, nolog or 
xi:logit cac75phadj shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==4, nolog or 
* Age P-Value 
xi:logit cac75phadj shscat2 i.shscat2*i.agecat1c i.agecat1c gender1 i.race1c i.site1c 
educ1cat income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or  
test _IshsXage_1_2 _IshsXage_1_3 _IshsXage_1_4 
 
* Race/Ethnicity  
* White 
xi:logit cac75phadj shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==1, nolog or 
* Chinnese 
xi:logit cac75phadj shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==2, nolog or 
* Black 
xi:logit cac75phadj shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==3, nolog or 
* Hispanic 
xi:logit cac75phadj shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==4, nolog or 
* Race P-Value 
xi:logit cac75phadj shscat2 i.shscat2*i.race1c gender1 i.agecat1 i.race1c i.site1c 
educ1cat income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 




xi:logit cac75phadj shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==3, nolog or 
* Col 
xi:logit cac75phadj shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==4, nolog or 
* JHU 
xi:logit cac75phadj shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==5, nolog or 
* UMN 
xi:logit cac75phadj shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==6, nolog or 
* NWU 
xi:logit cac75phadj shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==7, nolog or 
* UCLA 
xi:logit cac75phadj shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==8, nolog or 
* Site P-Value 
xi:logit cac75phadj shscat2 i.shscat2*i.site1c gender1 i.agecat1 i.race1c i.site1c 
educ1cat income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
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test _IshsXsit_1_4 _IshsXsit_1_5 _IshsXsit_1_6 _IshsXsit_1_7 _IshsXsit_1_8 
 
* Education, 2 categories 
* High school or less 
xi:logit cac75phadj shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==0, nolog or 
* More than high school 
xi:logit cac75phadj shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==1, nolog or 
* Education P-Value 
xi:logit cac75phadj shscat2 i.shscat2*educ1cat gender1 i.agecat1 i.race1c i.site1c 
educ1cat income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXeduc1_1 
 
* Smoking Status  
* Never 
xi:logit cac75phadj shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==0, nolog or 
* Former 
xi:logit cac75phadj shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==1, nolog or 
* Smoking Status P-Value 
xi:logit cac75phadj shscat2 i.shscat2*cig1c gender1 i.agecat1 i.race1c i.site1c educ1cat 




*** CAC>0 ********** 
******************** 
* Overall 
xi:logit caczero shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
* Females  
xi:logit caczero shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==0, nolog or 
* Males 
xi:logit caczero shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==1, nolog or 
* Sex P-Value 
xi:logit caczero shscat2 i.shscat2*gender1 gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXgende_1 
 
* Age  
xi:logit caczero shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==1, nolog or 
xi:logit caczero shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==2, nolog or 
xi:logit caczero shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==3, nolog or 
xi:logit caczero shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==4, nolog or 
* Age P-Value 
xi:logit caczero shscat2 i.shscat2*i.agecat1c i.agecat1c gender1 i.race1c i.site1c 
educ1cat income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXage_1_2 _IshsXage_1_3 _IshsXage_1_4 
 
* Race/Ethnicity  
* White 
xi:logit caczero shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==1, nolog or 
* Chinnese 
xi:logit caczero shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==2, nolog or 
* Black 
xi:logit caczero shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==3, nolog or 
* Hispanic 
xi:logit caczero shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==4, nolog or 
* Race P-Value 
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xi:logit caczero shscat2 i.shscat2*i.race1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 




xi:logit caczero shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==3, nolog or 
* Col 
xi:logit caczero shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==4, nolog or 
* JHU 
xi:logit caczero shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==5, nolog or 
* UMN 
xi:logit caczero shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==6, nolog or 
* NWU 
xi:logit caczero shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==7, nolog or 
* UCLA 
xi:logit caczero shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==8, nolog or 
* Site P-Value 
xi:logit caczero shscat2 i.shscat2*i.site1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXsit_1_4 _IshsXsit_1_5 _IshsXsit_1_6 _IshsXsit_1_7 _IshsXsit_1_8 
 
* Education, 2 categories 
* High school or less 
xi:logit caczero shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==0, nolog or 
* More than high school 
xi:logit caczero shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==1, nolog or 
* Education P-Value 
xi:logit caczero shscat2 i.shscat2*educ1cat gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXeduc1_1 
 
* Smoking Status  
* Never 
xi:logit caczero shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==0, nolog or 
* Former 
xi:logit caczero shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==1, nolog or 
* Smoking Status P-Value 
xi:logit caczero shscat2 i.shscat2*cig1c gender1 i.agecat1 i.race1c i.site1c educ1cat 




*** ABI Low (<=1) ********* 
*************************** 
* Overall 
xi:logit abi1low shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
* Females  
xi:logit abi1low shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==0, nolog or 
* Males 
xi:logit abi1low shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==1, nolog or 
* Sex P-Value 
xi:logit abi1low shscat2 i.shscat2*gender1 gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXgende_1 
 
* Age  
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xi:logit abi1low shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==1, nolog or 
xi:logit abi1low shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==2, nolog or 
xi:logit abi1low shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==3, nolog or 
xi:logit abi1low shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==4, nolog or 
* Age P-Value 
xi:logit abi1low shscat2 i.shscat2*i.agecat1c i.agecat1c gender1 i.race1c i.site1c 
educ1cat income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXage_1_2 _IshsXage_1_3 _IshsXage_1_4 
 
* Race/Ethnicity  
* White 
xi:logit abi1low shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==1, nolog or 
* Chinnese 
xi:logit abi1low shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==2, nolog or 
* Black 
xi:logit abi1low shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==3, nolog or 
* Hispanic 
xi:logit abi1low shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==4, nolog or 
* Race P-Value 
xi:logit abi1low shscat2 i.shscat2*i.race1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 




xi:logit abi1low shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==3, nolog or 
* Col 
xi:logit abi1low shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==4, nolog or 
* JHU 
xi:logit abi1low shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==5, nolog or 
* UMN 
xi:logit abi1low shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==6, nolog or 
* NWU 
xi:logit abi1low shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==7, nolog or 
* UCLA 
xi:logit abi1low shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==8, nolog or 
* Site P-Value 
xi:logit abi1low shscat2 i.shscat2*i.site1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXsit_1_4 _IshsXsit_1_5 _IshsXsit_1_6 _IshsXsit_1_7 _IshsXsit_1_8 
 
* Education, 2 categories 
* High school or less 
xi:logit abi1low shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==0, nolog or 
* More than high school 
xi:logit abi1low shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==1, nolog or 
* Education P-Value 
xi:logit abi1low shscat2 i.shscat2*educ1cat gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXeduc1_1 
 
* Smoking Status  
* Never 
xi:logit abi1low shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 




xi:logit abi1low shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==1, nolog or 
* Smoking Status P-Value 
xi:logit abi1low shscat2 i.shscat2*cig1c gender1 i.agecat1 i.race1c i.site1c educ1cat 




*** ABI Low (<=0.9) ******* 
*************************** 
* Overall 
xi:logit abi1low2 shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
* Females  
xi:logit abi1low2 shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==0, nolog or 
* Males 
xi:logit abi1low2 shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==1, nolog or 
* Sex P-Value 
xi:logit abi1low2 shscat2 i.shscat2*gender1 gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXgende_1 
 
* Age  
xi:logit abi1low2 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==1, nolog or 
xi:logit abi1low2 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==2, nolog or 
xi:logit abi1low2 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==3, nolog or 
xi:logit abi1low2 shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==4, nolog or 
* Age P-Value 
xi:logit abi1low2 shscat2 i.shscat2*i.agecat1c i.agecat1c gender1 i.race1c i.site1c 
educ1cat income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or  
test _IshsXage_1_2 _IshsXage_1_3 _IshsXage_1_4 
 
* Race/Ethnicity  
* White 
xi:logit abi1low2 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==1, nolog or 
* Chinnese 
xi:logit abi1low2 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==2, nolog or 
* Black 
xi:logit abi1low2 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==3, nolog or 
* Hispanic 
xi:logit abi1low2 shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==4, nolog or 
* Race P-Value 
xi:logit abi1low2 shscat2 i.shscat2*i.race1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 




xi:logit abi1low2 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==3, nolog or 
* Col 
xi:logit abi1low2 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==4, nolog or 
* JHU 
xi:logit abi1low2 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==5, nolog or 
* UMN 
xi:logit abi1low2 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 




xi:logit abi1low2 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==7, nolog or 
* UCLA 
xi:logit abi1low2 shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==8, nolog or 
* Site P-Value 
xi:logit abi1low2 shscat2 i.shscat2*i.site1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXsit_1_4 _IshsXsit_1_5 _IshsXsit_1_6 _IshsXsit_1_7 _IshsXsit_1_8 
 
* Education, 2 categories 
* High school or less 
xi:logit abi1low2 shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==0, nolog or 
* More than high school 
xi:logit abi1low2 shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==1, nolog or 
* Education P-Value 
xi:logit abi1low2 shscat2 i.shscat2*educ1cat gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXeduc1_1 
 
* Smoking Status  
* Never 
xi:logit abi1low2 shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==0, nolog or 
* Former 
xi:logit abi1low2 shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==1, nolog or 
* Smoking Status P-Value 
xi:logit abi1low2 shscat2 i.shscat2*cig1c gender1 i.agecat1 i.race1c i.site1c educ1cat 




*** ABI High (>=1.4) ********* 
*************************** 
* Overall 
xi:logit abi1high shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
* Females  
xi:logit abi1high shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==0, nolog or 
* Males 
xi:logit abi1high shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==1, nolog or 
* Sex P-Value 
xi:logit abi1high shscat2 i.shscat2*gender1 gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXgende_1 
 
* Age  
xi:logit abi1high shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==1, nolog or 
xi:logit abi1high shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==2, nolog or 
xi:logit abi1high shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==3, nolog or 
xi:logit abi1high shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==4, nolog or 
* Age P-Value 
xi:logit abi1high shscat2 i.shscat2*i.agecat1c i.agecat1c gender1 i.race1c i.site1c 
educ1cat income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or  
test _IshsXage_1_2 _IshsXage_1_3 _IshsXage_1_4 
 
* Race/Ethnicity  
* White 
xi:logit abi1high shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 




xi:logit abi1high shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==2, nolog or 
* Black 
xi:logit abi1high shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==3, nolog or 
* Hispanic 
xi:logit abi1high shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==4, nolog or 
* Race P-Value 
xi:logit abi1high shscat2 i.shscat2*i.race1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 




xi:logit abi1high shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==3, nolog or 
* Col 
xi:logit abi1high shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==4, nolog or 
* JHU 
xi:logit abi1high shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==5, nolog or 
* UMN 
xi:logit abi1high shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==6, nolog or 
* NWU 
xi:logit abi1high shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==7, nolog or 
* UCLA 
xi:logit abi1high shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==8, nolog or 
* Site P-Value 
xi:logit abi1high shscat2 i.shscat2*i.site1c gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXsit_1_4 _IshsXsit_1_5 _IshsXsit_1_6 _IshsXsit_1_7 _IshsXsit_1_8 
 
* Education, 2 categories 
* High school or less 
xi:logit abi1high shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==0, nolog or 
* More than high school 
xi:logit abi1high shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==1, nolog or 
* Education P-Value 
xi:logit abi1high shscat2 i.shscat2*educ1cat gender1 i.agecat1 i.race1c i.site1c educ1cat 
income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXeduc1_1 
 
* Smoking Status  
* Never 
xi:logit abi1high shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==0, nolog or 
* Former 
xi:logit abi1high shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==1, nolog or 
* Smoking Status P-Value 
xi:logit abi1high shscat2 i.shscat2*cig1c gender1 i.agecat1 i.race1c i.site1c educ1cat 




*** ABI Combined (>=1.4) ** 
*************************** 
* Overall 
xi:logit abi1combined shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat 
htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
* Females  
xi:logit abi1combined shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 




xi:logit abi1combined shscat2 i.agecat1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if gender==1, nolog or 
* Sex P-Value 
xi:logit abi1combined shscat2 i.shscat2*gender1 gender1 i.agecat1 i.race1c i.site1c 
educ1cat income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXgende_1 
 
* Age  
xi:logit abi1combined shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==1, nolog or 
xi:logit abi1combined shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==2, nolog or 
xi:logit abi1combined shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==3, nolog or 
xi:logit abi1combined shscat2 gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if agecat1c==4, nolog or 
* Age P-Value 
xi:logit abi1combined shscat2 i.shscat2*i.agecat1c i.agecat1c gender1 i.race1c i.site1c 
educ1cat income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or  
test _IshsXage_1_2 _IshsXage_1_3 _IshsXage_1_4 
 
* Race/Ethnicity  
* White 
xi:logit abi1combined shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==1, nolog or 
* Chinnese 
xi:logit abi1combined shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==2, nolog or 
* Black 
xi:logit abi1combined shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==3, nolog or 
* Hispanic 
xi:logit abi1combined shscat2 gender1 i.agecat1 i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if race1c==4, nolog or 
* Race P-Value 
xi:logit abi1combined shscat2 i.shscat2*i.race1c gender1 i.agecat1 i.race1c i.site1c 
educ1cat income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 




xi:logit abi1combined shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==3, nolog or 
* Col 
xi:logit abi1combined shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==4, nolog or 
* JHU 
xi:logit abi1combined shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==5, nolog or 
* UMN 
xi:logit abi1combined shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==6, nolog or 
* NWU 
xi:logit abi1combined shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==7, nolog or 
* UCLA 
xi:logit abi1combined shscat2 gender1 i.agecat1 i.race1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if site1c==8, nolog or 
* Site P-Value 
xi:logit abi1combined shscat2 i.shscat2*i.site1c gender1 i.agecat1 i.race1c i.site1c 
educ1cat income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXsit_1_4 _IshsXsit_1_5 _IshsXsit_1_6 _IshsXsit_1_7 _IshsXsit_1_8 
 
* Education, 2 categories 
* High school or less 
xi:logit abi1combined shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==0, nolog or 
* More than high school 
xi:logit abi1combined shscat2 gender1 i.agecat1 i.race1c i.site1c income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c if educ1cat==1, nolog or 
* Education P-Value 
 
 68 
xi:logit abi1combined shscat2 i.shscat2*educ1cat gender1 i.agecat1 i.race1c i.site1c 
educ1cat income1cat htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
test _IshsXeduc1_1 
 
* Smoking Status  
* Never 
xi:logit abi1combined shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat 
htn1c dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==0, nolog or 
* Former 
xi:logit abi1combined shscat2 gender1 i.agecat1 i.race1c i.site1c educ1cat income1cat 
htn1c dm031ccat ldl1 lipid1c pamvcm1c bmi1c if cig1c==1, nolog or 
* Smoking Status P-Value 
xi:logit abi1combined shscat2 i.shscat2*cig1c gender1 i.agecat1 i.race1c i.site1c 





** Aim 3:To assess if the association of secondhand smoke with atherosclerosis  
** is fully, partially, or not mediated by inflammation.  
** Hypothesis: Inflammation is a partial mediator of the association between  











* Adjust for current alcohol use 
******************************************************************************** 
*********************** Current Alcohol Use ************************************  
******************************************************************************** 
*************** 
*** hsCRP ***** 
***************  
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1 
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1 
 
*************** 
*** hsCRP>=2 ** 
*************** 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1, nolog or 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1, nolog or 
 
*************** 
**** IL-6 ***** 
*************** 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1 
 
**************** 
** Fibrinogen ** 
**************** 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1 
 
******************** 




xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1 
 
******************** 
*** Common cIMT ** 
******************** 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1 
 
******************** 
*** CAC>75th ******* 
******************** 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1, nolog or 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1, nolog or 
 
******************** 
*** CAC>0 ********** 
******************** 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1, nolog or 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1, nolog or 
 
*************************** 
*** ABI Low (<=1) ********* 
*************************** 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1, nolog or 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1, nolog or 
 
*************************** 
*** ABI Low (<=0.9) ******* 
*************************** 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1, nolog or 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1, nolog or 
 
*************************** 
*** ABI High(≥1.40 ******** 
*************************** 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1, nolog or 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1, nolog or 
 
* Adjusting for education based on more categories 
* educ1cat2 
******************************************************************************** 




*** hsCRP ***** 
***************  
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1 
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1 
 
*************** 




xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1, nolog or 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1, nolog or 
 
*************** 
**** IL-6 ***** 
*************** 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1 
 
**************** 
** Fibrinogen ** 
**************** 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1 
 
******************** 
*** Internal cIMT ** 
******************** 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1 
 
******************** 
*** Common cIMT ** 
******************** 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1 
 
******************** 
*** CAC>75th ******* 
******************** 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1, nolog or 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1, nolog or 
 
******************** 
*** CAC>0 ********** 
******************** 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1, nolog or 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1, nolog or 
 
*************************** 
*** ABI Low (<=1) ********* 
*************************** 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1, nolog or 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1, nolog or 
 
*************************** 
*** ABI Low (<=0.9) ******* 
*************************** 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1, nolog or 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1, nolog or 
 
*************************** 




xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c curalc1, nolog or 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c i.educ1cat2 income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c curalc1, nolog or 
 
 
* Adjusting for living with smoker as a child 
* qsmkcha4 
******************************************************************************** 




*** hsCRP ***** 
***************  
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkcha4 
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkcha4 
 
*************** 
*** hsCRP>=2 ** 
*************** 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkcha4, nolog or 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkcha4, nolog or 
 
*************** 
**** IL-6 ***** 
*************** 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkcha4 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkcha4 
 
**************** 
** Fibrinogen ** 
**************** 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkcha4 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkcha4 
 
******************** 
*** Internal cIMT ** 
******************** 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkcha4 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkcha4 
 
******************** 
*** Common cIMT ** 
******************** 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkcha4 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkcha4 
 
******************** 
*** CAC>75th ******* 
******************** 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkcha4, nolog or 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkcha4, nolog or 
 
******************** 




xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkcha4, nolog or 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkcha4, nolog or 
 
*************************** 
*** ABI Low (<=1) ********* 
*************************** 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkcha4, nolog or 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkcha4, nolog or 
 
*************************** 
*** ABI Low (<=0.9) ******* 
*************************** 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkcha4, nolog or 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkcha4, nolog or 
 
*************************** 
*** ABI High(≥1.40 ******** 
*************************** 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkcha4, nolog or 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkcha4, nolog or 
 
 
* Adjusting for living with smoker as an adult 
* qsmkada4 
******************************************************************************** 




*** hsCRP ***** 
***************  
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkada4 
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkada4 
 
*************** 
*** hsCRP>=2 ** 
*************** 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkada4, nolog or 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkada4, nolog or 
 
*************** 
**** IL-6 ***** 
*************** 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkada4 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkada4 
 
**************** 
** Fibrinogen ** 
**************** 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkada4 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkada4 
 
******************** 




xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkada4 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkada4 
 
******************** 
*** Common cIMT ** 
******************** 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkada4 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkada4 
 
******************** 
*** CAC>75th ******* 
******************** 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkada4, nolog or 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkada4, nolog or 
 
******************** 
*** CAC>0 ********** 
******************** 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkada4, nolog or 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkada4, nolog or 
 
*************************** 
*** ABI Low (<=1) ********* 
*************************** 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkada4, nolog or 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkada4, nolog or 
 
*************************** 
*** ABI Low (<=0.9) ******* 
*************************** 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkada4, nolog or 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkada4, nolog or 
 
*************************** 
*** ABI High(≥1.40 ******** 
*************************** 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c qsmkada4, nolog or 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c qsmkada4, nolog or 
 
 
* Adjusting for Family history 
******************************************************************************** 




*** hsCRP ***** 
***************  
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c fhha1c 
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c fhha1c 
 
*************** 




xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c fhha1c, nolog or 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c fhha1c, nolog or 
 
*************** 
**** IL-6 ***** 
*************** 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c fhha1c 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c fhha1c 
 
**************** 
** Fibrinogen ** 
**************** 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c fhha1c 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c fhha1c 
 
******************** 
*** Internal cIMT ** 
******************** 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c fhha1c 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c fhha1c 
 
******************** 
*** Common cIMT ** 
******************** 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c fhha1c 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c fhha1c 
 
******************** 
*** CAC>75th ******* 
******************** 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c fhha1c, nolog or 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c fhha1c, nolog or 
 
******************** 
*** CAC>0 ********** 
******************** 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c fhha1c, nolog or 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c fhha1c, nolog or 
 
*************************** 
*** ABI Low (<=1) ********* 
*************************** 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c fhha1c, nolog or 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c fhha1c, nolog or 
 
*************************** 
*** ABI Low (<=0.9) ******* 
*************************** 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c fhha1c, nolog or 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c fhha1c, nolog or 
 
*************************** 




xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c fhha1c, nolog or 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c fhha1c, nolog or 
 
 
* Adjusting for Heart rate  
*hrtrate1 
******************************************************************************** 




*** hsCRP ***** 
***************  
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c hrtrate1 
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c hrtrate1 
 
*************** 
*** hsCRP>=2 ** 
*************** 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c hrtrate1, nolog or 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c hrtrate1, nolog or 
 
*************** 
**** IL-6 ***** 
*************** 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c hrtrate1 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c hrtrate1 
 
**************** 
** Fibrinogen ** 
**************** 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c hrtrate1 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c hrtrate1 
 
******************** 
*** Internal cIMT ** 
******************** 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c hrtrate1 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c hrtrate1 
 
******************** 
*** Common cIMT ** 
******************** 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c hrtrate1 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c hrtrate1 
 
******************** 
*** CAC>75th ******* 
******************** 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c hrtrate1, nolog or 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c hrtrate1, nolog or 
 
******************** 




xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c hrtrate1, nolog or 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c hrtrate1, nolog or 
 
*************************** 
*** ABI Low (<=1) ********* 
*************************** 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c hrtrate1, nolog or 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c hrtrate1, nolog or 
 
*************************** 
*** ABI Low (<=0.9) ******* 
*************************** 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c hrtrate1, nolog or 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c hrtrate1, nolog or 
 
*************************** 
*** ABI High(≥1.40 ******** 
*************************** 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
i.dm031c ldl1 lipid1c pamvcm1c cig1c hrtrate1, nolog or 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
i.dm031c ldl1 lipid1c pamvcm1c cig1c bmi1c hrtrate1, nolog or 
 
******************************************************************************** 




*** hsCRP ***** 
***************  
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
* For P-for trend 
xi:reg logcrp shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logcrp shscat_median gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c 
xi:reg logcrp shscat_median gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
*************** 
*** hsCRP>=2 ** 
*************** 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
* For P-for trend 
xi:logit crp1cat shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog 
or 
xi:logit crp1cat shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit crp1cat shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************** 
**** IL-6 ***** 
*************** 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat 
 
 77 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
xi:reg logil61 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logil61 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logil61 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
**************** 
** Fibrinogen ** 
**************** 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
xi:reg logfib1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logfib1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logfib1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
******************************************************************************** 




*** Internal cIMT ** 
******************** 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
xi:reg logint1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logint1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logint1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
******************** 
*** Common cIMT ** 
******************** 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
xi:reg logcom1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logcom1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logcom1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
******************** 
*** CAC>75th ******* 
******************** 
* CAC>75th // Binary //  Using the mean: agatston calcium score, phantom-adjusted 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog 
or 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 




xi:logit cac75phadj shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, 
nolog or 
xi:logit cac75phadj shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit cac75phadj shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
******************** 
*** CAC>0 ********** 
******************** 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
xi:logit caczero shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog 
or 
xi:logit caczero shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit caczero shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI Low (<=1) ********* 
*************************** 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
xi:logit abi1low shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog 
or 
xi:logit abi1low shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1low shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI Low (<=0.9) ******* 
*************************** 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
xi:logit abi1low2 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, 
nolog or 
xi:logit abi1low2 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1low2 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI High(≥1.40 ******** 
*************************** 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
xi:logit abi1high shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, 
nolog or 
xi:logit abi1high shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1high shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 





*** ABI Combined ******** 
*************************** 
xi:logit abi1combined i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog 
or 
xi:logit abi1combined i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1combined i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
xi:logit abi1combined shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, 
nolog or 
xi:logit abi1combined shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1combined shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
******************************************************************************** 




*** hsCRP ***** 
***************  
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logcrp i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
* For P-for trend 
xi:reg logcrp shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logcrp shscat_median gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c 
xi:reg logcrp shscat_median gender1 i.race1c i.site1c educ1cat income1cat htn1c dm031ccat 
ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
*************** 
*** hsCRP>=2 ** 
*************** 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit crp1cat i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
* For P-for trend 
xi:logit crp1cat shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog 
or 
xi:logit crp1cat shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit crp1cat shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************** 
**** IL-6 ***** 
*************** 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logil61 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
xi:reg logil61 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logil61 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logil61 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
**************** 




xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logfib1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
xi:reg logfib1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logfib1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logfib1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
******************************************************************************** 




*** Internal cIMT ** 
******************** 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logint1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
xi:reg logint1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logint1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logint1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
******************** 
*** Common cIMT ** 
******************** 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logcom1 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
xi:reg logcom1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
xi:reg logcom1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c 
xi:reg logcom1 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c 
 
******************** 
*** CAC>75th ******* 
******************** 
* CAC>75th // Binary //  Using the mean: agatston calcium score, phantom-adjusted 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog 
or 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit cac75phadj i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
xi:logit cac75phadj shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, 
nolog or 
xi:logit cac75phadj shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit cac75phadj shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
******************** 
*** CAC>0 ********** 
******************** 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
 
 81 
xi:logit caczero i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
xi:logit caczero shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog 
or 
xi:logit caczero shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit caczero shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI Low (<=1) ********* 
*************************** 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1low i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
xi:logit abi1low shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog 
or 
xi:logit abi1low shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1low shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI Low (<=0.9) ******* 
*************************** 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1low2 i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
xi:logit abi1low2 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, 
nolog or 
xi:logit abi1low2 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1low2 shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI High(≥1.40 ******** 
*************************** 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog or 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1high i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
xi:logit abi1high shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat, 
nolog or 
xi:logit abi1high shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1high shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 
*************************** 
*** ABI Combined ******** 
*************************** 
xi:logit abi1combined i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat, nolog 
or 
xi:logit abi1combined i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1combined i.shscat age1c gender1 i.race1c i.site1c educ1cat income1cat htn1c 
dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
 




xi:logit abi1combined shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c, nolog or 
xi:logit abi1combined shscat_median age1c gender1 i.race1c i.site1c educ1cat income1cat 
htn1c dm031ccat ldl1 lipid1c pamvcm1c cig1c bmi1c, nolog or 
save "HMagid MESA Thesis Dataset_Final.dta", replace  
*************************** 
















































This is the R code for Figures 2-5 in Chapter 3. 
 
############################################################################# 
# Hoda Magid 
# JHSPH MHS Thesis  
# MESA Analysis 







###Plots for OR and GM Ratios of Subclinical CVD Outcomes by participant subgroups 
 
#set working directory and read data into R form, then save 
setwd ("C: Users/hodamagid/Dropbox/JHU Thesis/MESA Analysis Forest Plots/) 
 
############################################################### 
## Inflammation Plots: hsCRP and IL-6 
############################################################### 
infplot <-  read.csv("/Users/hodamagid/Dropbox/JHU Thesis/MESA Analysis Forest 
Plots/HMagid Thesis Forest Plot_hscrp_il6.csv", na=" ") 
save(infplot,file="infplot.rda") 
 
#load data in R form (to bypass the csv crap) 
load("infplot.rda") 
 
# FOR ALL PLOTS 
#Subgroup headings 
group <- c(expression(bold("Overall")), 
           expression(bold("Sex")), 
           expression(bold("Age, years")), 
           expression(bold("Race/Ethnicity")), 
           expression(bold("Study Site")), 
           expression(bold("Education")), 
           expression(bold("Smoking Status"))) 
 
#Categories within the subgroups 
label <- c("Men","Women","45-54","55-64", "65-74", "75-84",  
            "White","Chinnese-American","African-American", "Hispanic",  
            "Winston Salem", "New York City", "Baltimore", "Twin Cities",   
 "Chicago", "Los Angeles", 
            expression(paste(symbol("\243")," High School")),     
expression(paste(symbol("\076")," High School")), 
            "Never", "Former") 
             
y1 <- c(25:24,22:19,17:14,12:7,5:4,2:1)                # Y-values for GM Ratio for 
each subgroup (ex: men or women)  (and for N's) 
y2 <- c(27,26,23,18,13,6,3)                      # 
Y-values for subgroup labels (ex: Age, years) 
 
y3 <- c(25,24,23:22,20:18,16:14,12:10,8:7,5:4,2:1)                 # Y-values for GM 
Ratio for each subgroup and overall 
y4 <- c(27:1)                                                       # Y-values for GM 
Ratio (plot blanks too) 
 
sumlogcrpGMR95ci<-paste(format(infplot$sum_logcrp_GM, digits=2, nsmall=2)," 
(",format(infplot$sum_logcrp_GM_lower,digits=2),"-
",format(infplot$sum_logcrp_GM_upper,digits=3),")",sep="") 
sumlogcrpGMR95ci[c(2,5,10,15,22,25)] <- ""        # change "NA" to blank 
 
sumlogcrpGMR95p<-paste(format(infplot$sum_logcrp_GM_p, digits=1, nsmall=2)) 
sumlogcrpGMR95p[c(1,2,4,5,7,8,9,10,12,13,14,15,17:22,24:25,27)] <- ""                        
# change "NA" to blank 
 





sumlogil61GMR95ci[c(2,5,10,15,22,25)] <- ""        # change "NA" to blank 
 
sumlogil61GMR95p<-paste(format(infplot$sum_logil61_GM_p, digits=1, nsmall=2)) 
sumlogil61GMR95p[c(1,2,4,5,7,8,9,10,12,13,14,15,17:22,24:25,27)] <- ""                        
# change "NA" to blank 
 
num<-paste(format(infplot$X28.1, digits=1, nsmall=2)) 
 
par(mfrow=c(1,2), mar=c(4,4,4,4), oma=c(1,15,1,1)) 
 
############# 
#Plot for hscrp# 
############# 
plot(infplot$sum_logcrp_GM,infplot$X28,type='n',log="x",xlab=expression(bold("GM Ratio 
(95% CI)")), ylab="",axes=F,cex.lab=1, xlim=c(0.8,1.6)) 
 
mtext(side=2, at=29, expression(bold("Figure 2. Geometric Mean Ratio of hsCRP and IL-6 
Comparing Quartile 4 of Secondhand Smoke Exposure to Unexposed, Stratified by Participant 
Characteristics")),las=1,adj=0, cex=1.3, line=14.5)  #title 
 
mtext(side=2, at=28,"Characteristics",cex=1.0,font=4,las=1,adj=0,line=14.5)     # top 
heading for characteristics 
mtext(side=2, at=28, "N",font=4, las=1,adj=0, cex=1.0, line=7.5)                 # top 
heading for N's 
mtext(side=2, at=28, "hsCRP (95% CI)",font=4, las=1,adj=0, cex=1.0, line=6)  # for GM 
Ratio (95% CI) 
mtext(side=2, at=28, "P-int",font=4, las=1,adj=0, cex=1.0, line=-0.5)              # top 
heading for P interactions 
 
mtext(side=2,at=y2,group,cex=0.9,font=3,las=1,adj=0,line=14.5)                  # 
headings for group labels (ie gender, location) 
mtext(side=2,at=y1,label,cex=0.80,font=2,las=1,adj=0,line=13.5)                  # 
headings for subgroup labels (ie female, JHU) 
 
mtext(side=2,at=y4,sumlogcrpGMR95ci,cex=0.8,font=2,las=1,adj=0,line=5)                 # 
gives the GM Ratio (95% CI) for each subgroup 
mtext(side=2,at=y4,sumlogcrpGMR95p,cex=0.8,font=2,las=1,adj=0,line=-0.5)                    
# gives the p-interaction for as*subgroup 
mtext(side=2,at=y4,num,cex=0.8,font=2,las=1,adj=0,line=7.5)                    # gives 
the p-interaction for as*subgroup 
 
arrows(0.80,y4[9],0.809,y4[9], lty=1, lwd=2, col="black",length=0.05,code=1)      # Need 
to make the arrows for values that extend beyond x-axis 
segments(0.80,infplot$X28[9],infplot$sum_logcrp_GM_upper[9],infplot$X28[9],lty=1,lwd=2, 
col = "black") 
 
arrows(1.60,y4[12],1.51,y4[12], lty=1, lwd=2, col="black",length=0.05,code=1)      # Need 
to make the arrows for values that extend beyond x-axis 
segments(infplot$sum_logcrp_GM_lower[12],infplot$X28[12],1.6,infplot$X28[12],lty=1,lwd=2, 
col = "black") 
 
arrows(1.60,y4[16],1.51,y4[16], lty=1, lwd=2, col="black",length=0.05,code=1)      # Need 
to make the arrows for values that extend beyond x-axis 
segments(infplot$sum_logcrp_GM_lower[16],infplot$X28[16],1.6,infplot$X28[16],lty=1,lwd=2, 
col = "black") 
 
arrows(0.80,y4[17],0.809,y4[17], lty=1, lwd=2, col="black",length=0.05,code=1)      # 
Need to make the arrows for values that extend beyond x-axis 
segments(0.80,infplot$X28[17],infplot$sum_logcrp_GM_upper[17],infplot$X28[17],lty=1,lwd=2, 
col = "black") 
 
arrows(1.60,y4[18],1.51,y4[18], lty=1, lwd=2, col="black",length=0.05,code=1)      # Need 
to make the arrows for values that extend beyond x-axis 
segments(infplot$sum_logcrp_GM_lower[18],infplot$X28[18],1.6,infplot$X28[18],lty=1,lwd=2, 
col = "black") 
 
arrows(1.60,y4[21],1.51,y4[21], lty=1, lwd=2, col="black",length=0.05,code=1)      # Need 
to make the arrows for values that extend beyond x-axis 
segments(infplot$sum_logcrp_GM_lower[21],infplot$X28[21],1.6,infplot$X28[21],lty=1,lwd=2, 




abline(v=1,lty=1, lwd =2, col = "black")                                         # dashed 
red line at GM Ratio=1 
abline(v=c(1.13),lty=3, lwd =2, col = "black")                                   # solid 
blue line at overall GM Ratio 
points(infplot$sum_logcrp_GM,infplot$X28,pch=15, col = "black", cex=1.3)                
#plots the points 
segments(infplot$sum_logcrp_GM_lower[c(1:8,10,11,13:15,19,20,22:27)],infplot$X28[c(1:8,10
,11,13:15,19,20,22:27)],infplot$sum_logcrp_GM_upper[c(1:8,10,11,13:15,19,20,22:27)],infpl
ot$X28[c(1:8,10,11,13:15,19,20,22:27)],lty=1,lwd=2, col = "black")    #plots the lines 




#Plot for IL6# 
############# 
plot(infplot$sum_logil61_GM,infplot$X28,type='n',log="x",xlab=expression(bold("GM Ratio 
(95% CI)")), ylab="",axes=F,cex.lab=1, xlim=c(0.8,1.6)) 
 
mtext(side=2, at=28, "IL-6 (95% CI)",font=4, las=1,adj=0, cex=1, line=5.5)  # for GM 
Ratio (95% CI) 
 
mtext(side=2, at=28, "P-int",font=4, las=1,adj=0, cex=1, line=-0.5)              # top 
heading for P interactions 
 
mtext(side=2,at=y4,sumlogil61GMR95ci,cex=0.8,font=2,las=1,adj=0,line=5)                 # 
gives the GM Ratio (95% CI) for each subgroup 
mtext(side=2,at=y4,sumlogil61GMR95p,cex=0.8,font=2,las=1,adj=0,line=-0.5)                    
# gives the p-interaction for as*subgroup 
 
arrows(0.80,y4[12],0.809,y4[12], lty=1, lwd=2, col="black",length=0.05,code=1)      # 
Need to make the arrows for values that extend beyond x-axis 
segments(0.80,infplot$X28[12],infplot$sum_logil61_GM_upper[12],infplot$X28[12],lty=1,lwd=
2, col = "black") 
 
arrows(0.80,y4[20],0.809,y4[20], lty=1, lwd=2, col="black",length=0.05,code=1)      # 
Need to make the arrows for values that extend beyond x-axis 
segments(0.80,infplot$X28[20],infplot$sum_logil61_GM_upper[20],infplot$X28[20],lty=1,lwd=
2, col = "black") 
 
arrows(1.60,y4[21],1.51,y4[21], lty=1, lwd=2, col="black",length=0.05,code=1)      # Need 
to make the arrows for values that extend beyond x-axis 
segments(infplot$sum_logil61_GM_lower[21],infplot$X28[21],1.6,infplot$X28[21],lty=1,lwd=2, 
col = "black") 
 
abline(v=1,lty=1, lwd =2, col = "black")                                         # dashed 
red line at GM Ratio=1 
abline(v=c(1.05),lty=3, lwd =2, col = "black")                                   # solid 
blue line at overall GM Ratio 
points(infplot$sum_logil61_GM,infplot$X28,pch=15, col = "black", cex=1.3)                
#plots the points 
segments(infplot$sum_logil61_GM_lower[c(1:11,13:19,22:27)],infplot$X28[c(1:11,13:19,22:27
)],infplot$sum_logil61_GM_upper[c(1:11,13:19,22:27)],infplot$X28[c(1:11,13:19,22:27)],lty
=1,lwd=2, col = "black")    #plots the lines 




## Subclinical Atherosclerosis Plots: Common and Internal cIMT 
############################################################### 
cimtplot <-  read.csv("/Users/hodamagid/Dropbox/JHU Thesis/MESA Analysis Forest 
Plots/HMagid Thesis Forest Plot_common_internal.csv", na=" ") 
save(cimtplot,file="cimtplot.rda") 
 
#load data in R form (to bypass the csv crap) 
load("cimtplot.rda") 
 
# FOR ALL PLOTS 
#Subgroup headings 
group <- c(expression(bold("Overall")), 
           expression(bold("Sex")), 
           expression(bold("Age, years")), 
 
 86 
           expression(bold("Race/Ethnicity")), 
           expression(bold("Study Site")), 
           expression(bold("Education")), 
           expression(bold("Smoking Status"))) 
 
#Categories within the subgroups 
label <- c("Men","Women","45-54","55-64", "65-74", "75-84",  
            "White","Chinnese-American","African-American", "Hispanic",  
            "Winston Salem", "New York City", "Baltimore", "Twin Cities",   
 "Chicago", "Los Angeles", 
            expression(paste(symbol("\243")," High School")),     
expression(paste(symbol("\076")," High School")), 
            "Never", "Former") 
             
y1 <- c(25:24,22:19,17:14,12:7,5:4,2:1)                # Y-values for GM Ratio for 
each subgroup (ex: men or women)  (and for N's) 
y2 <- c(27,26,23,18,13,6,3)                      # 
Y-values for subgroup labels (ex: Age, years) 
 
y3 <- c(25,24,23:22,20:18,16:14,12:10,8:7,5:4,2:1)                 # Y-values for GM 
Ratio for each subgroup and overall 
y4 <- c(27:1)                                                       # Y-values for GM 
Ratio (plot blanks too) 
 
sumlogcomGMR95ci<-paste(format(cimtplot$sum_logcom1_GM, digits=2, nsmall=2)," 
(",format(cimtplot$sum_logcom1_GM_lower,digits=2),"-
",format(cimtplot$sum_logcom1_GM_upper,digits=3),")",sep="") 
sumlogcomGMR95ci[c(2,5,10,15,22,25)] <- ""        # change "NA" to blank 
 
sumlogcomGMR95p<-paste(format(cimtplot$sum_logcom1_GM_p, digits=1, nsmall=2)) 
sumlogcomGMR95p[c(1,2,4,5,7,8,9,10,12,13,14,15,17:22,24:25,27)] <- ""                        
# change "NA" to blank 
 
sumlogintGMR95ci<-paste(format(cimtplot$sum_logint1_GM, digits=2, nsmall=2)," 
(",format(cimtplot$sum_logint1_GM_lower,digits=2),"-
",format(cimtplot$sum_logint1_GM_upper,digits=3),")",sep="") 
sumlogintGMR95ci[c(2,5,10,15,22,25)] <- ""        # change "NA" to blank 
 
sumlogintGMR95p<-paste(format(cimtplot$sum_logint1_GM_p, digits=1, nsmall=2)) 
sumlogintGMR95p[c(1,2,4,5,7,8,9,10,12,13,14,15,17:22,24:25,27)] <- ""                        
# change "NA" to blank 
 
num<-paste(format(infplot$X28.1, digits=1, nsmall=2)) 
 
par(mfrow=c(1,2), mar=c(4,4,4,4), oma=c(1,15,1,1)) 
 
############# 
#Plot for Common cIMT 
############# 
plot(cimtplot$sum_logcom1_GM,cimtplot$X28,type='n',log="x",xlab=expression(bold("GM Ratio 
(95% CI)")), ylab="",axes=F,cex.lab=1, xlim=c(0.9,1.1)) 
 
mtext(side=2, at=30, expression(bold("Figure 3. Geometric Mean Ratio of Common and 
Internal cIMT Comparing Quartile 4 of Secondhand Smoke Exposure to Unexposed, Stratified 
by Participant Characteristics")),las=1,adj=0, cex=1.2, line=14.5)  #title 
 
mtext(side=2, at=29,"Characteristics",cex=1,font=2,las=1,adj=0,line=14.5)     # top 
heading for characteristics 
mtext(side=2, at=29, "N",font=4, las=1,adj=0, cex=1, line=7.5)                 # top 
heading for N's 
mtext(side=2, at=29, "Common cIMT",font=4, las=1,adj=0, cex=1, line=6)  # for GM Ratio 
(95% CI) 
mtext(side=2, at=28, "(95% CI)",font=4, las=1,adj=0, cex=1, line=5)  # for GM Ratio (95% 
CI) 
mtext(side=2, at=29, "P-int",font=4, las=1,adj=0, cex=1, line=-0.5)              # top 
heading for P interactions 
 
mtext(side=2,at=y2,group,cex=0.9,font=3,las=1,adj=0,line=14.5)                  # 
headings for group labels (ie gender, location) 
mtext(side=2,at=y1,label,cex=0.8,font=2,las=1,adj=0,line=13.5)                  # 




mtext(side=2,at=y4,sumlogcomGMR95ci,cex=0.8,font=2,las=1,adj=0,line=5)                 # 
gives the GM Ratio (95% CI) for each subgroup 
mtext(side=2,at=y4,sumlogcomGMR95p,cex=0.8,font=2,las=1,adj=0,line=-0.5)                    
# gives the p-interaction for as*subgroup 
mtext(side=2,at=y4,num,cex=0.8,font=2,las=1,adj=0,line=7.5)                    # gives 













Johns Hopkins University, Bloomberg School of Public Health                 Baltimore, Maryland                                                                                                         
Masters of Health Science; Epidemiology, Environmental Epidemiology Track  
Certificate: Risk Sciences and Public Policy 
9/10-6/12 Santa Clara University                                                                                Santa Clara, California 
Bachelors of Science in Biology and Public Health Sciences, June 2012 
Emphasis in Biomedical Sciences 






American Heart Association                                                                           Baltimore, Maryland        
A-TRAC Fellow 
 AHA Tobacco Regulation and Addiction Center (A-TRAC) fellow working with Michael 
Blaha MD MPH (Director of Clinical Research, Ciccarone Center for the Prevention of 
Heart Disease; Assistant Professor of Medicine; Johns Hopkins University)  
o Current research study: Alternate Tobacco Product Use in Patients Admitted with 
Myocardial Infarction 
 Through an AHA developed curriculum, developing a strong knowledge base in Tobacco 
Regulatory Science (TRS), the adverse effects of tobacco use on the human body, and an 
understanding of history, legislation and current events around tobacco use and regulation.  
 Membership and trans-TCORS (Tobacco Centers of Regulatory Science) or intra-cohort 
collaborations in TRS-related organizations (SRNT, APHA, AHA, etc.).  
 Participating in TRS activities at the local, state or federal level; and in TRS conferences or 
educational venues, including teaching and presenting on TRS topics.  
7/13-
Present 
Johns Hopkins University Bloomberg School of Public Health                  Baltimore, Maryland 
Environmental Health Sciences/Institute for Global Tobacco Control                     
Graduate Research Assistant  
 Conducting descriptive statistical and multivariable analysis; and data management for research 
projects funded by the Bloomberg Foundation for Tobacco Control. Current projects include: 
o Secondhand Smoke Exposure in Water Pipe Venues in Turkey, Russia, and Egypt. 
o Compliance with smoke-free tobacco legislation in public places: A 12-city study in 
  Turkey. 
 Under direction of Principal Investigators: conducting and maintaining quality control protocols for 
data management and data analysis.  
 Contributing to the interpretation and reporting of the study findings 
 Being in frequent and direct contact with the study principal investigator, the project coordinator, 





Johns Hopkins University Department of Biostatistics                             Baltimore, Maryland        
Graduate Teaching Assistant 
 Holding TA office hours and Stata office hours for the main Biostatistics course sequence at JHSPH 
(approximately 560 students). 
 Grading problem sets, quizzes, and exams.  
 Working with core Biostatistics departmental faculty during weekly instructor meetings. 
1/14-
Present 
Johns Hopkins University Department of Epidemiology                            Baltimore, Maryland        
Section Instructor and Graduate Teaching Assistant 
 Leading bi-weekly lab sessions with lab instructor for 50 graduate public health students  
 Holding TA office hours for the main Epidemiology course sequence at JHSPH (approximately 260 
students). 
 Grading assignments, quizzes, and exams.  
 Working with core Epidemiology departmental faculty during weekly instructor meetings. 
 Served as a Section Instructor for Undergraduate Epidemiology Course during the Spring 2014 
semester: led weekly lab sections on my own for 25 undergraduate public health students. 
 Drafted and graded homework, exam questions, and annotated keys. 
8/12-12/12 Egyptian Ministry of Youth                                                                                          Cairo, Egypt 
Assistant Program Coordinator 
• Assisted in the development of the Ministry's next anti-smoking campaign (original launch 
date before project termination was February 2013) targeting youth.  
• Collaborated with health professionals from the Egyptian Ministry of Health and the World 
Health Organization's Eastern Mediterranean Regional Office. 
• Trained 25 seminar instructors to facilitate prospective anti-smoking seminars for youth 
ages 12-19. 




California Family Health Council                                                                   Berkeley, California 
Public Affairs Intern  
 Assisted in the execution and promotion of CFHC’s online reproductive health resource, 
TeenSource.org, for California youth. 
 Worked to increase social media interaction with target audience (via SEO analysis of 
TeenSource.org and Facebook advertising campaign). 
 Managed all of TeenSource’s social media accounts.  
 Assisted in the execution of various public affairs and community health programs 
including TeenSource's  “Clinic Locator”, federally funded “Condom Access Project”, and 
“Nurse D”  (a Q&A forum on Tumblr). 
 Researched and wrote original weekly blog articles about teen sexual health topics and 
developed strategic partnerships with other health bloggers through social media. 













JHSPH Graduate Student Assembly                                                           Baltimore, Maryland 
Epidemiology Department Representative 




Student Clinical Opportunities for Premedical Experience                         Stanford, California 
Hospital Volunteer/Student Intern 
9/11-12/11 
 
BUILD Academic Incubator                                                                           Palo Alto, California 
Academic Mentor 




TechWadi                                                                                                         Palo Alto, California 
Tech Startup Mentorship Program Coordinator  
10/10-12/11 Santa Clara University Wellness Center                                                  Santa Clara, California 
Peer Health Educator 
6/09-9/09 Dar Al Fouad Hospital, Cardiology Department                                                      Cairo, Egypt 




4/14 International Society for Environmental Epidemiology 
 Student Travel Award, Abstract Accepted for Student Poster Presentation 
3/14 The Dorothy and Arthur Samet Student Support Fund in the Department of Epidemiology 
 $2,000 Endowed student award selected through Epidemiology faculty nomination only 
2/14 JHSPH Delta Omega Scientific Poster Competition 
 Applied Research, Third Place; Poster Title: “Compliance with Smoke-Free Tobacco 
Legislation in Indoor Public Places in 12 Cities in Turkey (Phase 1)" 
4/11-7/11 
 
Düzce University / Santa Clara University Global Fellowship Program             Düzce, Turkey 
Technology Training Instructor  
• Designed and developed two 2-week technology training seminars for 60 K-12 Turkish 
science and math teachers from Düzce.  
• Focused seminars on the implementation of technology into Turkish classroom in order to 
advance and facilitate student learning in underserved communities. 
• Trained teachers in educational software including Khan Academy, CK12, and University 
Subtitles. 




Ohlone College Chemistry Department                                                          Fremont, California 
Student Instructor  
• Planned and taught tri-weekly one hour and one-on-one tutorial supplemental instruction 
sessions for fifty first and second year college chemistry students. 
• Created weekly concept review handouts to academically support students struggling with 
course readings, concepts, and lecture materials.  
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2/13 University of California, Los Angeles Fielding School of Public Health 
• Future Public Health Leaders Fellowship: $24,000 of tuition support and $5,000 research 
support 
• Dean’s Leadership Grant: $20,000 of tuition support.  
3/13 Boston University School of Public Health  




Master’s Thesis (Proposal Approved) 
Title: Secondhand Tobacco Smoke and Subclinical Cardiovascular Disease: The Multiethnic Study of 
Atherosclerosis 
Lead Authors: Hoda Magid and Ana Navas-Acien MD PhD 
Co-authors: Michael J Blaha MD MPH, Miranda Jones PhD, Joel D. Kaufman MD MPH, Karen H 
Stukovsky, John W McEvoy MB BCh, Mahmoud Al-Rifai MD, MPH, Wendy S Post MD MS, R 
Graham Barr MD DrPH, Moyses Szklo MD DrPH, Joseph Pollack MD MPH, Gregory Burke 
 
Submitted Publications 
1. Moon, K. Magid, H., Susan,J., Torrey, C., Levshin, V., Çarkoğlu
, 
A., Nasr, G., El Rabbat, M. Cohen, J. 
  Strickland, P, Navas-Acien A. Breysse, P. Secondhand Smoke Exposure in Water Pipe Venues in 
Turkey, Russia, and Egypt. Environmental Health Perspectives.  
 
Selected Peer-reviewed Publications In Preparation 




G. Hayran, M. Ergüder, T. Kaplan, B. Pollak, J. Susan, J. 
  Cohen, J. Navas-Acien, A. PM2.5 Levels in Hospitality Venues in 12 Cities in Turkey.  




G. Hayran, M. Ergüder, T. Kaplan, B. Pollak, J. Susan, J. 
  Cohen, J. Navas-Acien, A. Smoking and Secondhand Tobacco Smoke in Taxi Cabs in 12 Cities in 
  Turkey.  




G. Hayran, M. Ergüder, T. Kaplan, B. Magid, H. Moon, K. Pollak, 
J.   Susan, J. Cohen, J. Compliance with smoke-free tobacco legislation in public places: A 12-city 
study in   Turkey.  
 
Ongoing Research Support 
 
Food and Drug Administration  Michael Blaha / Diann Gaalema (PI)                       10/01/2014-
Present    
American Heart Association    
The goal of this study is to characterize recent tobacco use in hospitalized cardiac patients and to track 
how tobacco use changes after recovery from their cardiovascular event, including the use of e-cigarettes. This 
survey, funded by the FDA as part of the TCORS at the University of Vermont, focuses on the use of e-
cigarettes in patients hospitalized with myocardial infarction with 3 months of follow-up. For this project, the 
Johns Hopkins A-TRAC site is collaborating with Diann Gaalema (University of Vermont). As an integral 
member of the research team, I will be working on the data collection, management, analysis, interpretation, 
and dissemination alongside Dr. Michael Blaha and the rest of the Johns Hopkins A-TRAC study team. 
Role: Research Fellow 
 




The goal of this study is to characterize water pipe secondhand smoke composition and quantify secondhand 
smoke exposure among water pipe venue employees in 3 cities: Istanbul, Turkey, Moscow, Russia, and Cairo, 
Egypt. Tobacco control efforts largely exempt water pipe venues, although the prevalence is high and growing 
in many parts of the world. Laboratory studies suggest that water pipe secondhand smoke contains increased 
levels of nicotine, carbon monoxide (CO), polycyclic aromatic hydrocarbons (PAHs), and formaldehyde 
compared with cigarettes. Most previous studies use laboratory data not representative of real-world exposures 
and do not investigate potential exposure of nearby non-smokers or venue employees. 
  Role: Research Assistant 
 
Bloomberg Initiative for Tobacco Control                        Navas-Acien (PI)                05/01/2012-
12/31/2014   
The goal of this study is to apply and evaluate the smoke-free compliance guide in 12 cities around Turkey, in 
order to evaluate the current level of compliance with the Turkish smoke-free law. In 2008, Turkey passed a law 
banning smoking in all indoor public places, including bars, cafes and restaurants as well as outdoor areas in 
hospitals and mosques. No systematic evaluation of the level of implementation and enforcement of the 
legislation has been conducted. 
Role: Research Assistant 
 
LABORATORY/STATISTICAL ANALYSIS SKILLS 
• Biology/Statistics Software: R, Stata, 
Mesquite, Mega, and BioEdit 
• PCR and Gel Electrophoresis  
• Western Blots  
• Fluorescence Microscopy  
• Immunohistochemistry 
• Animal Cell Growth Cultures 
• Protein/DNA Array
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
